These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
(Mark One) | |||||
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|
|
||||||||||
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification Number) |
Title of each class | Trading Symbol | Name of each exchange on which registered | ||||||||||||
|
|
|
|
☑ | Accelerated Filer | ☐ | ||||||||
Non-accelerated Filer | ☐ | Smaller Reporting Company |
|
||||||||
(Do not check if a smaller reporting company) | Emerging growth company |
|
PART I – FINANCIAL INFORMATION | Page No. | |||||||
PART II – OTHER INFORMATION | ||||||||
Mar. 30, 2024 | Jul. 1, 2023 | ||||||||||||||||
(unaudited) | |||||||||||||||||
ASSETS | |||||||||||||||||
Current assets | |||||||||||||||||
Cash and cash equivalents | $ |
|
$ |
|
|||||||||||||
Accounts receivable, less allowances of $
|
|
|
|||||||||||||||
Inventories |
|
|
|||||||||||||||
Prepaid expenses and other current assets |
|
|
|||||||||||||||
Income tax receivable |
|
|
|||||||||||||||
Total current assets |
|
|
|||||||||||||||
Plant and equipment at cost, less accumulated depreciation |
|
|
|||||||||||||||
Other long-term assets | |||||||||||||||||
Goodwill |
|
|
|||||||||||||||
Intangibles, less amortization |
|
|
|||||||||||||||
Deferred income taxes |
|
|
|||||||||||||||
Operating lease right-of-use assets, net |
|
|
|||||||||||||||
Other assets |
|
|
|||||||||||||||
Total other long-term assets |
|
|
|||||||||||||||
Total assets | $ |
|
$ |
|
|||||||||||||
LIABILITIES AND SHAREHOLDERS’ EQUITY | |||||||||||||||||
Current liabilities | |||||||||||||||||
Accounts payable | $ |
|
$ |
|
|||||||||||||
Accrued expenses |
|
|
|||||||||||||||
Accrued income taxes |
|
|
|||||||||||||||
Current operating lease liabilities |
|
|
|||||||||||||||
Current maturities of long-term debt |
|
|
|||||||||||||||
Total current liabilities |
|
|
|||||||||||||||
Long-term liabilities | |||||||||||||||||
Long-term debt |
|
|
|||||||||||||||
Deferred income taxes |
|
|
|||||||||||||||
Long-term operating lease liabilities |
|
|
|||||||||||||||
Other long-term liabilities |
|
|
|||||||||||||||
Total long-term liabilities |
|
|
|||||||||||||||
Noncontrolling interest |
|
|
|||||||||||||||
Shareholders’ equity | |||||||||||||||||
Preferred stock, par value $
|
|
|
|||||||||||||||
Common stock, par value $
|
|
|
|||||||||||||||
Paid-in capital |
|
|
|||||||||||||||
Retained earnings |
|
|
|||||||||||||||
Accumulated other comprehensive loss |
(
|
(
|
|||||||||||||||
Treasury stock at cost,
|
(
|
(
|
|||||||||||||||
Total shareholders’ equity |
|
|
|||||||||||||||
Total liabilities and shareholders’ equity | $ |
|
$ |
|
13-Week Period Ended | 39-Week Period Ended | ||||||||||||||||||||||
Mar. 30, 2024 | Apr. 1, 2023 | Mar. 30, 2024 | Apr. 1, 2023 | ||||||||||||||||||||
Sales | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Cost of sales |
|
|
|
|
|||||||||||||||||||
Gross profit |
|
|
|
|
|||||||||||||||||||
Operating expenses |
|
|
|
|
|||||||||||||||||||
Operating income |
|
|
|
|
|||||||||||||||||||
Interest expense |
|
|
|
|
|||||||||||||||||||
Other expense (income), net
(1) (2)
|
|
|
|
|
|||||||||||||||||||
Earnings before income taxes |
|
|
|
|
|||||||||||||||||||
Income taxes |
|
|
|
|
|||||||||||||||||||
Net earnings | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Net earnings: | |||||||||||||||||||||||
Basic earnings per share | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Diluted earnings per share |
|
|
|
|
|||||||||||||||||||
Average shares outstanding |
|
|
|
|
|||||||||||||||||||
Diluted shares outstanding |
|
|
|
|
(1)
|
Gains and losses related to the disposition of fixed assets have been recognized within operating expenses. Prior year amounts have been reclassified to conform to this presentation.
|
||||
(2)
|
Sysco’s second quarter of fiscal 2023 included a charge of $
|
13-Week Period Ended | 39-Week Period Ended | ||||||||||||||||||||||||||||
Mar. 30, 2024 | Apr. 1, 2023 | Mar. 30, 2024 | Apr. 1, 2023 | ||||||||||||||||||||||||||
Net earnings | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||
Other comprehensive income (loss): | |||||||||||||||||||||||||||||
Foreign currency translation adjustment |
(
|
|
(
|
|
|||||||||||||||||||||||||
Items presented net of tax: | |||||||||||||||||||||||||||||
Amortization of cash flow hedges |
|
|
|
|
|||||||||||||||||||||||||
Change in net investment hedges |
|
(
|
(
|
(
|
|||||||||||||||||||||||||
Change in cash flow hedges |
|
(
|
|
(
|
|||||||||||||||||||||||||
Changes in excluded components of fair value hedge |
|
|
|
|
|||||||||||||||||||||||||
Amortization of prior service cost |
|
|
|
|
|||||||||||||||||||||||||
Amortization of actuarial loss |
|
|
|
|
|||||||||||||||||||||||||
Pension settlement charge |
|
|
|
|
|||||||||||||||||||||||||
Net actuarial (loss) gain arising in current year |
|
|
|
(
|
|||||||||||||||||||||||||
Change in marketable securities |
(
|
|
|
(
|
|||||||||||||||||||||||||
Total other comprehensive income (loss) |
(
|
|
|
|
|||||||||||||||||||||||||
Comprehensive income | $ |
|
$ |
|
$ |
|
$ |
|
Accumulated
Other Comprehensive Loss |
|||||||||||||||||||||||||||||||||||||||||||||||
Common Stock |
Paid-in
Capital |
Retained
Earnings |
Treasury Stock | ||||||||||||||||||||||||||||||||||||||||||||
Shares | Amount | Shares | Amounts | Totals | |||||||||||||||||||||||||||||||||||||||||||
Balance as of December 30, 2023 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
|
$ |
(
|
$ |
|
|||||||||||||||||||||||||||||||||
Net earnings |
|
|
|||||||||||||||||||||||||||||||||||||||||||||
Other comprehensive income |
(
|
(
|
|||||||||||||||||||||||||||||||||||||||||||||
Dividends declared ($
|
(
|
(
|
|||||||||||||||||||||||||||||||||||||||||||||
Treasury stock purchases |
(
|
|
(
|
(
|
|||||||||||||||||||||||||||||||||||||||||||
Share-based compensation awards |
|
(
|
|
|
|||||||||||||||||||||||||||||||||||||||||||
Balance as of March 30, 2024 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
|
$ |
(
|
$ |
|
|||||||||||||||||||||||||||||||||
Accumulated
Other Comprehensive Loss |
|||||||||||||||||||||||||||||||||||||||||||||||
Common Stock |
Paid-in
Capital |
Retained
Earnings |
Treasury Stock | ||||||||||||||||||||||||||||||||||||||||||||
Shares | Amount | Shares | Amounts | Totals | |||||||||||||||||||||||||||||||||||||||||||
Balance as of December 31, 2022 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
|
$ |
(
|
$ |
|
|||||||||||||||||||||||||||||||||
Net earnings |
|
|
|||||||||||||||||||||||||||||||||||||||||||||
Other comprehensive income |
|
|
|||||||||||||||||||||||||||||||||||||||||||||
Dividends declared ($
|
(
|
(
|
|||||||||||||||||||||||||||||||||||||||||||||
Treasury stock purchases |
|
(
|
(
|
||||||||||||||||||||||||||||||||||||||||||||
Share-based compensation awards |
|
(
|
|
|
|||||||||||||||||||||||||||||||||||||||||||
Balance as of April 1, 2023 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
|
$ |
(
|
$ |
|
Accumulated
Other Comprehensive Loss |
|||||||||||||||||||||||||||||||||||||||||||||||
Common Stock |
Paid-in
Capital |
Retained
Earnings |
Treasury Stock | ||||||||||||||||||||||||||||||||||||||||||||
Shares | Amount | Shares | Amounts | Totals | |||||||||||||||||||||||||||||||||||||||||||
Balance as of July 1, 2023 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
|
$ |
(
|
$ |
|
|||||||||||||||||||||||||||||||||
Net earnings |
|
|
|||||||||||||||||||||||||||||||||||||||||||||
Other comprehensive income |
|
|
|||||||||||||||||||||||||||||||||||||||||||||
Dividends declared ($
|
(
|
(
|
|||||||||||||||||||||||||||||||||||||||||||||
Treasury stock purchases |
(
|
|
(
|
(
|
|||||||||||||||||||||||||||||||||||||||||||
Share-based compensation awards |
|
(
|
|
|
|||||||||||||||||||||||||||||||||||||||||||
Balance as of March 30, 2024 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
|
$ |
(
|
$ |
|
|||||||||||||||||||||||||||||||||
Accumulated
Other Comprehensive Loss |
|||||||||||||||||||||||||||||||||||||||||||||||
Common Stock |
Paid-in
Capital |
Retained
Earnings |
Treasury Stock | ||||||||||||||||||||||||||||||||||||||||||||
Shares | Amount | Shares | Amounts | Totals | |||||||||||||||||||||||||||||||||||||||||||
Balance as of July 2, 2022 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
|
$ |
(
|
$ |
|
|||||||||||||||||||||||||||||||||
Net earnings |
|
|
|||||||||||||||||||||||||||||||||||||||||||||
Other comprehensive income |
|
|
|||||||||||||||||||||||||||||||||||||||||||||
Dividends declared ($
|
(
|
(
|
|||||||||||||||||||||||||||||||||||||||||||||
Treasury stock purchases |
|
(
|
(
|
||||||||||||||||||||||||||||||||||||||||||||
Increase in ownership interest in subsidiaries |
(
|
(
|
|||||||||||||||||||||||||||||||||||||||||||||
Share-based compensation awards |
|
(
|
|
|
|||||||||||||||||||||||||||||||||||||||||||
Balance as of April 1, 2023 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
|
$ |
(
|
$ |
|
39-Week Period Ended | |||||||||||
Mar. 30, 2024 | Apr. 1, 2023 | ||||||||||
Cash flows from operating activities: | |||||||||||
Net earnings | $ |
|
$ |
|
|||||||
Adjustments to reconcile net earnings to cash provided by operating activities: | |||||||||||
Pension settlement charge |
|
|
|||||||||
Share-based compensation expense |
|
|
|||||||||
Depreciation and amortization |
|
|
|||||||||
Operating lease asset amortization |
|
|
|||||||||
Amortization of debt issuance and other debt-related costs |
|
|
|||||||||
Deferred income taxes |
(
|
(
|
|||||||||
Provision for losses on receivables |
|
|
|||||||||
Other non-cash items |
(
|
|
|||||||||
Additional changes in certain assets and liabilities, net of effect of businesses acquired: | |||||||||||
Increase in receivables |
(
|
(
|
|||||||||
Increase in inventories |
(
|
(
|
|||||||||
Decrease (increase) in prepaid expenses and other current assets |
|
(
|
|||||||||
(Decrease) increase in accounts payable |
(
|
|
|||||||||
Increase (decrease) in accrued expenses |
|
(
|
|||||||||
Decrease in operating lease liabilities |
(
|
(
|
|||||||||
(Decrease) increase in accrued income taxes |
(
|
|
|||||||||
Decrease in other assets |
|
|
|||||||||
Increase (decrease) in other long-term liabilities |
|
(
|
|||||||||
Net cash provided by operating activities |
|
|
|||||||||
Cash flows from investing activities: | |||||||||||
Additions to plant and equipment |
(
|
(
|
|||||||||
Proceeds from sales of plant and equipment |
|
|
|||||||||
Acquisition of businesses, net of cash acquired |
(
|
(
|
|||||||||
Purchase of marketable securities |
(
|
(
|
|||||||||
Proceeds from sales of marketable securities |
|
|
|||||||||
Other investing activities |
|
|
|||||||||
Net cash used for investing activities |
(
|
(
|
|||||||||
Cash flows from financing activities: | |||||||||||
Bank and commercial paper borrowings, net |
|
|
|||||||||
Other debt borrowings including senior notes |
|
|
|||||||||
Other debt repayments including senior notes |
(
|
(
|
|||||||||
Debt issuance costs |
(
|
|
|||||||||
Proceeds from stock option exercises |
|
|
|||||||||
Stock repurchases |
(
|
(
|
|||||||||
Dividends paid |
(
|
(
|
|||||||||
Other financing activities |
(
|
(
|
|||||||||
Net cash provided by (used for) financing activities |
|
(
|
|||||||||
Effect of exchange rates on cash, cash equivalents and restricted cash |
(
|
|
|||||||||
Net decrease in cash, cash equivalents and restricted cash |
(
|
(
|
|||||||||
Cash, cash equivalents and restricted cash at beginning of period |
|
|
|||||||||
Cash, cash equivalents and restricted cash at end of period | $ |
|
$ |
|
|||||||
Supplemental disclosures of cash flow information: | |||||||||||
Cash paid during the period for: | |||||||||||
Interest | $ |
|
$ |
|
|||||||
Income taxes, net of refunds |
|
|
|||||||||
Mar. 30, 2024 | Apr. 1, 2023 | ||||||||||
(In thousands) | |||||||||||
Cash and cash equivalents | $ |
|
$ |
|
|||||||
Restricted cash
(1)
|
|
|
|||||||||
Total cash, cash equivalents and restricted cash shown in the consolidated statement of cash flows | $ |
|
$ |
|
(1)
|
Restricted cash primarily represents cash and cash equivalents of Sysco’s wholly owned captive insurance subsidiary, restricted for use to secure the insurer’s obligations for workers’ compensation, general liability and auto liability programs. Restricted cash is located within other assets in each consolidated balance sheet.
|
Mar. 30, 2024 | Apr. 1, 2023 | ||||||||||
(In thousands) | |||||||||||
Non-cash investing and financing activities: | |||||||||||
Plant and equipment acquired through financing programs | $ |
|
$ |
|
|||||||
Assets obtained in exchange for finance lease obligations |
|
|
Mar. 30, 2024 | Jul. 1, 2023 | Apr. 1, 2023 | Jul. 2, 2022 | |||||||||||||||||||||||||||||
(In thousands) | ||||||||||||||||||||||||||||||||
Financed payment obligations | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||
13-Week Period Ended Mar. 30, 2024 | ||||||||||||||||||||||||||||||||
US Foodservice Operations | International Foodservice Operations | SYGMA | Other | Total | ||||||||||||||||||||||||||||
(In thousands) | ||||||||||||||||||||||||||||||||
Principal Product Categories | ||||||||||||||||||||||||||||||||
Canned and dry products | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||
Fresh and frozen meats |
|
|
|
|
|
|||||||||||||||||||||||||||
Frozen fruits, vegetables, bakery and other |
|
|
|
|
|
|||||||||||||||||||||||||||
Dairy products |
|
|
|
|
|
|||||||||||||||||||||||||||
Poultry |
|
|
|
|
|
|||||||||||||||||||||||||||
Fresh produce |
|
|
|
|
|
|||||||||||||||||||||||||||
Paper and disposables |
|
|
|
|
|
|||||||||||||||||||||||||||
Seafood |
|
|
|
|
|
|||||||||||||||||||||||||||
Beverage products |
|
|
|
|
|
|||||||||||||||||||||||||||
Equipment and smallwares
(1)
|
|
|
|
|
|
|||||||||||||||||||||||||||
Other
(2)
|
|
|
|
|
|
|||||||||||||||||||||||||||
Total Sales | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
(1)
|
Due to the acquisition of Edward Don & Company (Edward Don), a distributor of foodservice equipment and supplies, “Equipment and smallwares” is now presented as a separate principal product category. See Note 4, “Acquisitions,” for details on this acquisition. | ||||
(2)
|
Other sales relate to certain non-food products, including textiles and amenities for our hotel supply business, other janitorial products, and medical supplies.
|
13-Week Period Ended Apr. 1, 2023 | ||||||||||||||||||||||||||||||||
US Foodservice Operations | International Foodservice Operations | SYGMA | Other | Total | ||||||||||||||||||||||||||||
(In thousands) | ||||||||||||||||||||||||||||||||
Principal Product Categories | ||||||||||||||||||||||||||||||||
Canned and dry products | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||
Fresh and frozen meats |
|
|
|
|
|
|||||||||||||||||||||||||||
Frozen fruits, vegetables, bakery and other |
|
|
|
|
|
|||||||||||||||||||||||||||
Dairy products |
|
|
|
|
|
|||||||||||||||||||||||||||
Poultry |
|
|
|
|
|
|||||||||||||||||||||||||||
Fresh produce |
|
|
|
|
|
|||||||||||||||||||||||||||
Paper and disposables |
|
|
|
|
|
|||||||||||||||||||||||||||
Seafood |
|
|
|
|
|
|||||||||||||||||||||||||||
Beverage products |
|
|
|
|
|
|||||||||||||||||||||||||||
Equipment and smallwares
(1)
|
|
|
|
|
|
|||||||||||||||||||||||||||
Other
(2)
|
|
|
|
|
|
|||||||||||||||||||||||||||
Total Sales | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
(1)
|
Due to the acquisition of Edward Don & Company (Edward Don), a distributor of foodservice equipment and supplies, “Equipment and smallwares” is now presented as a separate principal product category. See Note 4, “Acquisitions,” for details on this acquisition. | ||||
(2)
|
Other sales relate to certain non-food products, including textiles and amenities for our hotel supply business, other janitorial products, and medical supplies.
|
39-Week Period Ended Mar. 30, 2024 | ||||||||||||||||||||||||||||||||
US Foodservice Operations | International Foodservice Operations | SYGMA | Other | Total | ||||||||||||||||||||||||||||
(In thousands) | ||||||||||||||||||||||||||||||||
Principal Product Categories | ||||||||||||||||||||||||||||||||
Canned and dry products | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||
Fresh and frozen meats |
|
|
|
|
|
|||||||||||||||||||||||||||
Frozen fruits, vegetables, bakery and other |
|
|
|
|
|
|||||||||||||||||||||||||||
Dairy products |
|
|
|
|
|
|||||||||||||||||||||||||||
Poultry |
|
|
|
|
|
|||||||||||||||||||||||||||
Fresh produce |
|
|
|
|
|
|||||||||||||||||||||||||||
Paper and disposables |
|
|
|
|
|
|||||||||||||||||||||||||||
Seafood |
|
|
|
|
|
|||||||||||||||||||||||||||
Beverage products |
|
|
|
|
|
|||||||||||||||||||||||||||
Equipment and smallwares
(1)
|
|
|
|
|
|
|||||||||||||||||||||||||||
Other
(2)
|
|
|
|
|
|
|||||||||||||||||||||||||||
Total Sales | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
(1)
|
Due to the acquisition of Edward Don & Company (Edward Don), a distributor of foodservice equipment and supplies, “Equipment and smallwares” is now presented as a separate principal product category. See Note 4, “Acquisitions,” for details on this acquisition. | ||||
(2)
|
Other sales relate to certain non-food products, including textiles and amenities for our hotel supply business, other janitorial products, and medical supplies.
|
39-Week Period Ended Apr. 1, 2023 | ||||||||||||||||||||||||||||||||
US Foodservice Operations | International Foodservice Operations | SYGMA | Other | Total | ||||||||||||||||||||||||||||
(In thousands) | ||||||||||||||||||||||||||||||||
Principal Product Categories | ||||||||||||||||||||||||||||||||
Canned and dry products | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||
Fresh and frozen meats |
|
|
|
|
|
|||||||||||||||||||||||||||
Frozen fruits, vegetables, bakery and other |
|
|
|
|
|
|||||||||||||||||||||||||||
Dairy products |
|
|
|
|
|
|||||||||||||||||||||||||||
Poultry |
|
|
|
|
|
|||||||||||||||||||||||||||
Fresh produce |
|
|
|
|
|
|||||||||||||||||||||||||||
Paper and disposables |
|
|
|
|
|
|||||||||||||||||||||||||||
Seafood |
|
|
|
|
|
|||||||||||||||||||||||||||
Beverage products |
|
|
|
|
|
|||||||||||||||||||||||||||
Equipment and smallwares
(1)
|
|
|
|
|
|
|||||||||||||||||||||||||||
Other
(2)
|
|
|
|
|
|
|||||||||||||||||||||||||||
Total Sales | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
(1)
|
Due to the acquisition of Edward Don & Company (Edward Don), a distributor of foodservice equipment and supplies, “Equipment and smallwares” is now presented as a separate principal product category. See Note 4, “Acquisitions,” for details on this acquisition. | ||||
(2)
|
Other sales relate to certain non-food products, including textiles and amenities for our hotel supply business, other janitorial products, and medical supplies.
|
Assets Measured at Fair Value as of Mar. 30, 2024 | |||||||||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | ||||||||||||||||||||
(In thousands) | |||||||||||||||||||||||
Assets: | |||||||||||||||||||||||
Cash equivalents | |||||||||||||||||||||||
Cash and cash equivalents | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Other assets
(1)
|
|
|
|
|
|||||||||||||||||||
Total assets at fair value | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
(1)
|
Represents restricted cash balance recorded within other assets in the consolidated balance sheet. |
Assets Measured at Fair Value as of Jul. 1, 2023 | |||||||||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | ||||||||||||||||||||
(In thousands) | |||||||||||||||||||||||
Assets: | |||||||||||||||||||||||
Cash equivalents | |||||||||||||||||||||||
Cash and cash equivalents | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Other assets
(1)
|
|
|
|
|
|||||||||||||||||||
Total assets at fair value | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
(1)
|
Represents restricted cash balance recorded within other assets in the consolidated balance sheet. |
Mar. 30, 2024 | |||||||||||||||||||||||||||||||||||
Amortized Cost Basis | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | Short-Term Marketable Securities | Long-Term Marketable Securities | ||||||||||||||||||||||||||||||
(In thousands) | |||||||||||||||||||||||||||||||||||
Fixed income securities: | |||||||||||||||||||||||||||||||||||
Corporate bonds | $ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||
Government bonds |
|
|
(
|
|
|
|
|||||||||||||||||||||||||||||
Total marketable securities | $ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||
Jul. 1, 2023 | |||||||||||||||||||||||||||||||||||
Amortized Cost Basis | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | Short-Term Marketable Securities | Long-Term Marketable Securities | ||||||||||||||||||||||||||||||
(In thousands) | |||||||||||||||||||||||||||||||||||
Fixed income securities: | |||||||||||||||||||||||||||||||||||
Corporate bonds | $ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||
Government bonds |
|
|
(
|
|
|
|
|||||||||||||||||||||||||||||
Total marketable securities | $ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
Mar. 30, 2024 | |||||
(In thousands) | |||||
Due in one year or less | $ |
|
|||
Due after one year through five years |
|
||||
Due after five years |
|
||||
Total | $ |
|
Maturity Date of the Hedging Instrument | Currency / Unit of Measure | Notional Value | ||||||||||||
(In millions) | ||||||||||||||
Hedging of interest rate risk | ||||||||||||||
January 2034 | U.S. Dollar |
|
||||||||||||
Hedging of foreign currency risk | ||||||||||||||
Various (April 2024 to August 2024) | Swedish Krona |
|
||||||||||||
Various (April 2024 to October 2024) | British Pound Sterling |
|
||||||||||||
May 2024 | Mexican Peso |
|
||||||||||||
April 2025 | Canadian Dollar |
|
||||||||||||
January 2029 | Euro |
|
||||||||||||
Hedging of fuel risk | ||||||||||||||
Various (April 2024 to March 2026) | Gallons |
|
Derivative Fair Value | |||||||||||||||||
Balance Sheet location | Mar. 30, 2024 | Jul. 1, 2023 | |||||||||||||||
(In thousands) | |||||||||||||||||
Fair Value Hedges: | |||||||||||||||||
Interest rate swaps | Other assets | $ |
|
$ |
|
||||||||||||
Interest rate swaps | Other current liabilities |
|
|
||||||||||||||
Cross currency swaps | Other current liabilities |
|
|
||||||||||||||
Cross currency swaps | Other long-term liabilities |
|
|
||||||||||||||
Cash Flow Hedges: | |||||||||||||||||
Fuel swaps | Other current assets | $ |
|
$ |
|
||||||||||||
Foreign currency forwards | Other current assets |
|
|
||||||||||||||
Fuel swaps | Other assets |
|
|
||||||||||||||
Fuel swaps | Other current liabilities |
|
|
||||||||||||||
Foreign currency forwards | Other current liabilities |
|
|
||||||||||||||
Fuel swaps | Other long-term liabilities |
|
|
||||||||||||||
Net Investment Hedges: | |||||||||||||||||
Cross currency swaps | Other current assets | $ |
|
$ |
|
||||||||||||
Cross currency swaps | Other long-term liabilities |
|
|
||||||||||||||
13-Week Period Ended | 39-Week Period Ended | |||||||||||||||||||||||||
Mar. 30, 2024 | Apr. 1, 2023 | Mar. 30, 2024 | Apr. 1, 2023 | |||||||||||||||||||||||
(In thousands) | ||||||||||||||||||||||||||
Total amounts of income and expense line items presented in the consolidated results of operations in which the effects of fair value hedges are recorded | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
Gain or (loss) on fair value hedging relationships: | ||||||||||||||||||||||||||
Interest rate swaps: | ||||||||||||||||||||||||||
Hedged items | $ |
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||||||||||||||
Derivatives designated as hedging instruments |
(
|
(
|
|
(
|
||||||||||||||||||||||
Cross currency swaps: | ||||||||||||||||||||||||||
Hedged items | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
Derivatives designated as hedging instruments |
(
|
|
(
|
|
||||||||||||||||||||||
13-Week Period Ended | 39-Week Period Ended | |||||||||||||||||||||||||
Mar. 30, 2024 | Apr. 1, 2023 | Mar. 30, 2024 | Apr. 1, 2023 | |||||||||||||||||||||||
(In thousands) | ||||||||||||||||||||||||||
Interest expense | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||||||||||||||
Increase (decrease) in fair value of debt |
(
|
|
|
(
|
||||||||||||||||||||||
Foreign currency gain |
|
|
|
|
||||||||||||||||||||||
Hedged items | $ |
|
$ |
(
|
$ |
(
|
$ |
(
|
13-Week Period Ended Mar. 30, 2024 | |||||||||||||||||
Amount of Gain or (Loss) Recognized in Other Comprehensive Income on Derivatives | Location of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income into Income | Amount of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income into Income | |||||||||||||||
(In thousands) | (In thousands) | ||||||||||||||||
Derivatives in cash flow hedging relationships: | |||||||||||||||||
Fuel swaps | $ |
|
Operating expense | $ |
(
|
||||||||||||
Foreign currency contracts |
|
Cost of sales / Other income |
|
||||||||||||||
Total | $ |
|
$ |
(
|
|||||||||||||
Derivatives in net investment hedging relationships: | |||||||||||||||||
Cross currency contracts | $ |
|
N/A | $ |
|
||||||||||||
Derivatives in fair value hedging relationships: | |||||||||||||||||
Change in excluded component of fair value hedge | $ |
|
Other expense (income) | $ |
|
||||||||||||
13-Week Period Ended Apr. 1, 2023 | |||||||||||||||||
Amount of Gain or (Loss) Recognized in Other Comprehensive Income on Derivatives | Location of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income into Income | Amount of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income into Income | |||||||||||||||
(In thousands) | (In thousands) | ||||||||||||||||
Derivatives in cash flow hedging relationships: | |||||||||||||||||
Fuel swaps | $ |
(
|
Operating expense | $ |
(
|
||||||||||||
Foreign currency contracts |
(
|
Cost of sales / Other income |
|
||||||||||||||
Total | $ |
(
|
$ |
(
|
|||||||||||||
Derivatives in net investment hedging relationships: | |||||||||||||||||
Foreign denominated debt | $ |
(
|
N/A | $ |
|
||||||||||||
39-Week Period Ended Mar. 30, 2024 | |||||||||||||||||
Amount of Gain or (Loss) Recognized in Other Comprehensive Income on Derivatives | Location of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income into Income | Amount of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income into Income | |||||||||||||||
(In thousands) | (In thousands) | ||||||||||||||||
Derivatives in cash flow hedging relationships: | |||||||||||||||||
Fuel swaps | $ |
|
Operating expense | $ |
|
||||||||||||
Foreign currency contracts |
|
Cost of sales / Other income |
|
||||||||||||||
Total | $ |
|
$ |
|
|||||||||||||
Derivatives in net investment hedging relationships: | |||||||||||||||||
Cross currency contracts | $ |
(
|
N/A | $ |
|
||||||||||||
Derivatives in fair value hedging relationships: | |||||||||||||||||
Change in excluded component of fair value hedge | $ |
|
Other expense (income) | $ |
|
||||||||||||
39-Week Period Ended Apr. 1, 2023 | |||||||||||||||||
Amount of Gain or (Loss) Recognized in Other Comprehensive Income on Derivatives | Location of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income into Income | Amount of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income into Income | |||||||||||||||
(In thousands) | (In thousands) | ||||||||||||||||
Derivatives in cash flow hedging relationships: | |||||||||||||||||
Fuel swaps | $ |
(
|
Operating expense | $ |
|
||||||||||||
Foreign currency contracts |
(
|
Cost of sales / Other income |
|
||||||||||||||
Total | $ |
(
|
$ |
|
|||||||||||||
Derivatives in net investment hedging relationships: | |||||||||||||||||
Foreign denominated debt | $ |
(
|
N/A | $ |
|
||||||||||||
Mar. 30, 2024 | |||||||||||
Carrying Amount of Hedged Assets (Liabilities) | Cumulative Amount of Fair Value Hedging Adjustments Included in the Carrying Amount of Hedged Assets (Liabilities) | ||||||||||
(In thousands) | |||||||||||
Balance sheet location: | |||||||||||
Long-term debt | $ |
(
|
$ |
(
|
Maturity Date |
Par Value
(in millions) |
Coupon Rate |
Pricing
(percentage of par) |
||||||||||||||
January 17, 2029 (the 2029 Notes) | $ |
|
|
% |
|
% | |||||||||||
January 17, 2034 (the 2034 Notes) |
|
|
|
13-Week Period | 39-Week Period | ||||||||||||||||||||||
Ended
(1)
|
Ended
(1)
|
||||||||||||||||||||||
Apr. 1, 2023 | Apr. 1, 2023 | ||||||||||||||||||||||
(In thousands) | (In thousands) | ||||||||||||||||||||||
Service cost | $ |
|
$ |
|
|||||||||||||||||||
Interest cost |
|
|
|||||||||||||||||||||
Expected return on plan assets |
(
|
(
|
|||||||||||||||||||||
Amortization of prior service cost |
|
|
|||||||||||||||||||||
Amortization of actuarial loss |
|
|
|||||||||||||||||||||
Settlement loss recognized |
|
|
|||||||||||||||||||||
Net pension costs | $ |
|
$ |
|
(1)
|
Net pension costs were not material for the third quarter and first 39 weeks of fiscal 2024.
|
||||
13-Week Period Ended | 39-Week Period Ended | ||||||||||||||||||||||
Mar. 30, 2024 | Apr. 1, 2023 | Mar. 30, 2024 | Apr. 1, 2023 | ||||||||||||||||||||
(In thousands, except for share
and per share data) |
(In thousands, except for share
and per share data) |
||||||||||||||||||||||
Numerator: | |||||||||||||||||||||||
Net earnings | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Denominator: | |||||||||||||||||||||||
Weighted-average basic shares outstanding |
|
|
|
|
|||||||||||||||||||
Dilutive effect of share-based awards |
|
|
|
|
|||||||||||||||||||
Weighted-average diluted shares outstanding |
|
|
|
|
|||||||||||||||||||
Basic earnings per share | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Diluted earnings per share | $ |
|
$ |
|
$ |
|
$ |
|
13-Week Period Ended Mar. 30, 2024 | |||||||||||||||||||||||
Location of
Expense (Income) Recognized in Net Earnings |
Before Tax
Amount |
Tax |
Net of Tax
Amount |
||||||||||||||||||||
(In thousands) | |||||||||||||||||||||||
Foreign currency translation: | |||||||||||||||||||||||
Foreign currency translation adjustment | N/A | $ |
(
|
$ |
|
$ |
(
|
||||||||||||||||
Hedging instruments: | |||||||||||||||||||||||
Other comprehensive income (loss) before reclassification adjustments: | |||||||||||||||||||||||
Change in excluded component of fair value
hedge |
Other expense, net |
|
|
|
|||||||||||||||||||
Change in cash flow hedges |
Operating expenses
(1)
|
|
|
|
|||||||||||||||||||
Change in net investment hedges | N/A |
|
|
|
|||||||||||||||||||
Total other comprehensive (loss) before reclassification adjustments |
|
|
|
||||||||||||||||||||
Reclassification adjustments: | |||||||||||||||||||||||
Amortization of cash flow hedges | Interest expense |
|
|
|
|||||||||||||||||||
Pension and other postretirement benefit plans: | |||||||||||||||||||||||
Reclassification adjustments: | |||||||||||||||||||||||
Amortization of prior service cost | Other expense, net |
|
|
|
|||||||||||||||||||
Amortization of actuarial loss, net | Other expense, net |
|
|
|
|||||||||||||||||||
Total reclassification adjustments |
|
|
|
||||||||||||||||||||
Marketable securities: | |||||||||||||||||||||||
Change in marketable securities
(2)
|
N/A |
(
|
|
(
|
|||||||||||||||||||
Total other comprehensive income (loss) | $ |
(
|
$ |
|
$ |
(
|
(1)
|
Amount partially impacts operating expense for fuel swaps accounted for as cash flow hedges.
|
||||
(2)
|
Realized gains or losses on marketa
ble securities are presented within other (income) expense, net in the consolidated results of operations; however, there were
no
significant gains or losses realized in the third
quarter
of fiscal 2024.
|
13-Week Period Ended Apr. 1, 2023 | |||||||||||||||||||||||
Location of
Expense (Income) Recognized in Net Earnings |
Before Tax
Amount |
Tax |
Net of Tax
Amount |
||||||||||||||||||||
(In thousands) | |||||||||||||||||||||||
Foreign currency translation: | |||||||||||||||||||||||
Foreign currency translation adjustment | N/A | $ |
|
$ |
|
$ |
|
||||||||||||||||
Hedging instruments: | |||||||||||||||||||||||
Other comprehensive income (loss) before reclassification adjustments: | |||||||||||||||||||||||
Change in cash flow hedges |
Operating expenses
(1)
|
(
|
(
|
(
|
|||||||||||||||||||
Change in net investment hedges | N/A |
(
|
(
|
(
|
|||||||||||||||||||
Total other comprehensive (loss) before reclassification adjustments |
(
|
(
|
(
|
||||||||||||||||||||
Reclassification adjustments: | |||||||||||||||||||||||
Amortization of cash flow hedges | Interest expense |
|
|
|
|||||||||||||||||||
Pension and other postretirement benefit plans: | |||||||||||||||||||||||
Reclassification adjustments: | |||||||||||||||||||||||
Amortization of prior service cost | Other expense, net |
|
|
|
|||||||||||||||||||
Amortization of actuarial loss, net | Other expense, net |
|
|
|
|||||||||||||||||||
Total reclassification adjustments |
|
|
|
||||||||||||||||||||
Marketable securities: | |||||||||||||||||||||||
Change in marketable securities
(2)
|
N/A |
|
|
|
|||||||||||||||||||
Total other comprehensive income | $ |
|
$ |
(
|
$ |
|
(1)
|
Amount partially impacts operating expense for fuel swaps accounted for as cash flow hedges.
|
||||
(2)
|
Realized gains or losses on marketable securities are presented within other (income) expense, net in the consolidated results of operations; however, there were no significant gains or losses realized in the third quarter of fiscal 2023.
|
39-Week Period Ended Mar. 30, 2024 | |||||||||||||||||||||||
Location of
Expense (Income) Recognized in Net Earnings |
Before Tax
Amount |
Tax |
Net of Tax
Amount |
||||||||||||||||||||
(In thousands) | |||||||||||||||||||||||
Foreign currency translation: | |||||||||||||||||||||||
Foreign currency translation adjustment | N/A | $ |
(
|
$ |
|
$ |
(
|
||||||||||||||||
Hedging instruments: | |||||||||||||||||||||||
Other comprehensive income (loss) before reclassification adjustments: | |||||||||||||||||||||||
Change in excluded component of fair value
hedge |
Other expense, net |
|
|
|
|||||||||||||||||||
Change in cash flow hedges |
Operating expenses
(1)
|
|
|
|
|||||||||||||||||||
Change in net investment hedges | N/A |
(
|
(
|
(
|
|||||||||||||||||||
Total other comprehensive (loss) before reclassification adjustments |
|
|
|
||||||||||||||||||||
Reclassification adjustments: | |||||||||||||||||||||||
Amortization of cash flow hedges | Interest expense |
|
|
|
|||||||||||||||||||
Pension and other postretirement benefit plans: | |||||||||||||||||||||||
Other comprehensive income before reclassification adjustments: | |||||||||||||||||||||||
Net actuarial gain, arising in the current year |
|
|
|
||||||||||||||||||||
Reclassification adjustments: | |||||||||||||||||||||||
Amortization of prior service cost | Other expense, net |
|
|
|
|||||||||||||||||||
Amortization of actuarial loss, net | Other expense, net |
|
|
|
|||||||||||||||||||
Total reclassification adjustments |
|
|
|
||||||||||||||||||||
Marketable securities: | |||||||||||||||||||||||
Change in marketable securities
(2)
|
N/A |
|
|
|
|||||||||||||||||||
Total other comprehensive income | $ |
|
$ |
|
$ |
|
|||||||||||||||||
(1)
|
Amount partially impacts operating expense for fuel swaps accounted for as cash flow hedges.
|
||||
(2)
|
Realized gains or losses on marketable securities are presented within other (income) expense, net in the consolidated results of operations; however, there were no significant gains or losses realized in the first 39 weeks of fiscal 2024.
|
39-Week Period Ended Apr. 1, 2023 | |||||||||||||||||||||||
Location of
Expense (Income) Recognized in Net Earnings |
Before Tax
Amount |
Tax |
Net of Tax
Amount |
||||||||||||||||||||
(In thousands) | |||||||||||||||||||||||
Foreign currency translation: | |||||||||||||||||||||||
Foreign currency translation adjustment | N/A | $ |
|
$ |
|
$ |
|
||||||||||||||||
Hedging instruments: | |||||||||||||||||||||||
Other comprehensive (loss) before reclassification adjustments: | |||||||||||||||||||||||
Change in cash flow hedges |
Operating expenses
(1)
|
(
|
(
|
(
|
|||||||||||||||||||
Change in net investment hedges | N/A |
(
|
(
|
(
|
|||||||||||||||||||
Total other comprehensive (loss) before reclassification adjustments |
(
|
(
|
(
|
||||||||||||||||||||
Reclassification adjustments: | |||||||||||||||||||||||
Amortization of cash flow hedges | Interest expense |
|
|
|
|||||||||||||||||||
Pension and other postretirement benefit plans: | |||||||||||||||||||||||
Other comprehensive income before reclassification adjustments: | |||||||||||||||||||||||
Net actuarial loss, arising in the current year |
(
|
(
|
(
|
||||||||||||||||||||
Settlements | Other expense, net |
|
|
|
|||||||||||||||||||
Total other comprehensive income before reclassification adjustments |
|
|
|
||||||||||||||||||||
Reclassification adjustments: | |||||||||||||||||||||||
Amortization of prior service cost | Other expense, net |
|
|
|
|||||||||||||||||||
Amortization of actuarial loss, net | Other expense, net |
|
|
|
|||||||||||||||||||
Total reclassification adjustments |
|
|
|
||||||||||||||||||||
Marketable securities: | |||||||||||||||||||||||
Change in marketable securities
(2)
|
N/A |
(
|
(
|
(
|
|||||||||||||||||||
Total other comprehensive income | $ |
|
$ |
|
$ |
|
(1)
|
Amount partially impacts operating expense for fuel swaps accounted for as cash flow hedges.
|
||||
(2)
|
Realized gains or losses on marketable securities are presented within other (income) expense, net in the consolidated results of operations; however, there were no significant gains or losses realized in the first 39 weeks of fiscal 2023.
|
13-Week Period Ended Mar. 30, 2024 | |||||||||||||||||||||||||||||
Foreign Currency Translation |
Hedging,
net of tax |
Pension and Other Postretirement Benefit Plans,
net of tax |
Marketable Securities, net of tax | Total | |||||||||||||||||||||||||
(In thousands) | |||||||||||||||||||||||||||||
Balance as of Dec. 30, 2023 | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
|||||||||||||||||||
Equity adjustment from foreign currency translation |
(
|
— | — | — |
(
|
||||||||||||||||||||||||
Amortization of cash flow hedges | — |
|
— | — |
|
||||||||||||||||||||||||
Change in net investment hedges | — |
|
— | — |
|
||||||||||||||||||||||||
Change in cash flow hedges | — |
|
— | — |
|
||||||||||||||||||||||||
Change in excluded component of fair value hedge | — |
|
— | — |
|
||||||||||||||||||||||||
Amortization of unrecognized prior service cost | — | — |
|
— |
|
||||||||||||||||||||||||
Amortization of unrecognized net actuarial losses | — | — |
|
— |
|
||||||||||||||||||||||||
Change in marketable securities | — | — | — |
(
|
(
|
||||||||||||||||||||||||
Balance as of Mar. 30, 2024 | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
13-Week Period Ended Apr. 1, 2023 | |||||||||||||||||||||||||||||
Foreign Currency Translation |
Hedging,
net of tax |
Pension and Other Postretirement Benefit Plans,
net of tax |
Marketable Securities, net of tax | Total | |||||||||||||||||||||||||
(In thousands) | |||||||||||||||||||||||||||||
Balance as of Dec. 31, 2022 | $ |
(
|
$ |
|
$ |
(
|
$ |
(
|
$ |
(
|
|||||||||||||||||||
Equity adjustment from foreign currency translation |
|
— | — | — |
|
||||||||||||||||||||||||
Amortization of cash flow hedges | — |
|
— | — |
|
||||||||||||||||||||||||
Change in net investment hedges | — |
(
|
— | — |
(
|
||||||||||||||||||||||||
Change in cash flow hedges | — |
(
|
— | — |
(
|
||||||||||||||||||||||||
Amortization of unrecognized prior service cost | — | — |
|
— |
|
||||||||||||||||||||||||
Amortization of unrecognized net actuarial losses | — | — |
|
— |
|
||||||||||||||||||||||||
Change in marketable securities | — | — | — |
|
|
||||||||||||||||||||||||
Balance as of Apr. 1, 2023 | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
39-Week Period Ended Mar. 30, 2024 | |||||||||||||||||||||||||||||
Foreign Currency Translation |
Hedging,
net of tax |
Pension and Other Postretirement Benefit Plans,
net of tax |
Marketable Securities,
net of tax |
Total | |||||||||||||||||||||||||
(In thousands) | |||||||||||||||||||||||||||||
Balance as of Jul. 1, 2023 | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
|||||||||||||||||||
Equity adjustment from foreign currency translation |
(
|
— | — | — |
(
|
||||||||||||||||||||||||
Amortization of cash flow hedges | — |
|
— | — |
|
||||||||||||||||||||||||
Change in net investment hedges | — |
(
|
— | — |
(
|
||||||||||||||||||||||||
Change in cash flow hedges | — |
|
— | — |
|
||||||||||||||||||||||||
Change in excluded component of fair value hedge | — |
|
— | — |
|
||||||||||||||||||||||||
Amortization of unrecognized prior service cost | — | — |
|
— |
|
||||||||||||||||||||||||
Amortization of unrecognized net actuarial losses | — | — |
|
— |
|
||||||||||||||||||||||||
Net actuarial loss arising in the current year | — | — |
|
— |
|
||||||||||||||||||||||||
Change in marketable securities | — | — | — |
|
|
||||||||||||||||||||||||
Balance as of Mar. 30, 2024 | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
39-Week Period Ended Apr. 1, 2023 | |||||||||||||||||||||||||||||
Foreign Currency Translation |
Hedging,
net of tax |
Pension and Other Postretirement Benefit Plans,
net of tax |
Marketable Securities, net of tax | Total | |||||||||||||||||||||||||
(In thousands) | |||||||||||||||||||||||||||||
Balance as of Jul. 2, 2022 | $ |
(
|
$ |
|
$ |
(
|
$ |
(
|
$ |
(
|
|||||||||||||||||||
Equity adjustment from foreign currency translation |
|
— | — | — |
|
||||||||||||||||||||||||
Amortization of cash flow hedges | — |
|
— | — |
|
||||||||||||||||||||||||
Change in net investment hedges | — |
(
|
— | — |
(
|
||||||||||||||||||||||||
Change in cash flow hedges | — |
(
|
— | — |
(
|
||||||||||||||||||||||||
Amortization of unrecognized prior service cost | — | — |
|
— |
|
||||||||||||||||||||||||
Amortization of unrecognized net actuarial losses | — | — |
|
— |
|
||||||||||||||||||||||||
Settlements | — | — |
|
— |
|
||||||||||||||||||||||||
Net actuarial loss arising in the current year | — | — |
(
|
— |
(
|
||||||||||||||||||||||||
Change in marketable securities | — | — | — |
(
|
(
|
||||||||||||||||||||||||
Balance as of Apr. 1, 2023 | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
13-Week Period Ended | 39-Week Period Ended | ||||||||||||||||||||||
Mar. 30, 2024 | Apr. 1, 2023 | Mar. 30, 2024 | Apr. 1, 2023 | ||||||||||||||||||||
Sales: | (In thousands) | (In thousands) | |||||||||||||||||||||
U.S. Foodservice Operations | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
International Foodservice Operations |
|
|
|
|
|||||||||||||||||||
SYGMA |
|
|
|
|
|||||||||||||||||||
Other |
|
|
|
|
|||||||||||||||||||
Total | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
13-Week Period Ended | 39-Week Period Ended | ||||||||||||||||||||||
Mar. 30, 2024 | Apr. 1, 2023 | Mar. 30, 2024 | Apr. 1, 2023 | ||||||||||||||||||||
Operating income (loss): | (In thousands) | (In thousands) | |||||||||||||||||||||
U.S. Foodservice Operations | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
International Foodservice Operations |
|
|
|
|
|||||||||||||||||||
SYGMA |
|
|
|
|
|||||||||||||||||||
Other |
|
|
|
|
|||||||||||||||||||
Total segments |
|
|
|
|
|||||||||||||||||||
Global Support Center |
(
|
(
|
(
|
(
|
|||||||||||||||||||
Total operating income |
|
|
|
|
|||||||||||||||||||
Interest expense |
|
|
|
|
|||||||||||||||||||
Other expense, net |
|
|
|
|
|||||||||||||||||||
Earnings before income taxes | $ |
|
$ |
|
$ |
|
$ |
|
13-Week Period Ended | 39-Week Period Ended | ||||||||||||||||||||||
Mar. 30, 2024 | Apr. 1, 2023 | Mar. 30, 2024 | Apr. 1, 2023 | ||||||||||||||||||||
Sales | 100.0 | % | 100.0 | % | 100.0 | % | 100.0 | % | |||||||||||||||
Cost of sales | 81.4 | 81.8 | 81.5 | 81.9 | |||||||||||||||||||
Gross profit | 18.6 | 18.2 | 18.5 | 18.1 | |||||||||||||||||||
Operating expenses | 14.9 | 14.5 | 14.7 | 14.4 | |||||||||||||||||||
Operating income | 3.7 | 3.7 | 3.8 | 3.7 | |||||||||||||||||||
Interest expense | 0.7 | 0.8 | 0.8 | 0.7 | |||||||||||||||||||
Other expense (income), net | 0.1 | — | — | 0.7 | |||||||||||||||||||
Earnings before income taxes | 2.9 | 2.9 | 3.0 | 2.3 | |||||||||||||||||||
Income taxes | 0.7 | 0.6 | 0.7 | 0.5 | |||||||||||||||||||
Net earnings | 2.2 | % | 2.3 | % | 2.3 | % | 1.8 | % |
13-Week Period Ended | 39-Week Period Ended | ||||||||||
Mar. 30, 2024 | Mar. 30, 2024 | ||||||||||
Sales | 2.7 | % | 3.0 | % | |||||||
Cost of sales | 2.1 | 2.6 | |||||||||
Gross profit | 5.2 | 4.9 | |||||||||
Operating expenses | 5.5 | 4.2 | |||||||||
Operating income | 3.8 | 7.3 | |||||||||
Interest expense | 17.0 | 13.0 | |||||||||
Other expense (income), net
(1) (2)
|
53.6 | (93.7) | |||||||||
Earnings before income taxes | — | 32.7 | |||||||||
Income taxes | 3.8 | 43.7 | |||||||||
Net earnings | (1.1) | % | 29.6 | % | |||||||
Basic earnings per share | — | % | 30.9 | % | |||||||
Diluted earnings per share | 1.2 | 31.0 | |||||||||
Average shares outstanding | (1.6) | (0.9) | |||||||||
Diluted shares outstanding | (1.6) | (1.0) |
(1)
|
Other expense (income), net was expense of $10.4 million and $6.8 million in the third quarter of fiscal 2024 and fiscal 2023, respectively.
|
||||
(2)
|
Other expense (income), net was expense of $22.3 million and $354.8 million in the first 39 weeks of fiscal 2024 and fiscal 2023, respectively.
|
13-Week Period Ended Mar. 30, 2024 | |||||||||||||||||||||||||||||||||||
U.S. Foodservice Operations | International Foodservice Operations | SYGMA | Other | Global Support Center |
Consolidated
Totals |
||||||||||||||||||||||||||||||
(In thousands) | |||||||||||||||||||||||||||||||||||
Sales | $ | 13,707,108 | $ | 3,493,232 | $ | 1,903,922 | $ | 275,238 | $ | — | $ | 19,379,500 | |||||||||||||||||||||||
Sales increase (decrease) | 3.4 | % | 4.5 | % | (3.5) | % | (8.9) | % | 2.7 | % | |||||||||||||||||||||||||
Percentage of total | 70.7 | % | 18.0 | % | 9.8 | % | 1.5 | % | 100.0 | % | |||||||||||||||||||||||||
Operating income (loss) | $ | 852,444 | $ | 83,898 | $ | 16,805 | $ | 6,371 | $ | (237,472) | $ | 722,046 | |||||||||||||||||||||||
Operating income (loss) increase (decrease) | (0.5) | % | 73.9 | % | (34.4) | % | (46.2) | % | (3.9) | % | 3.8 | % | |||||||||||||||||||||||
Percentage of total segments | 88.8 | % | 8.7 | % | 1.8 | % | 0.7 | % | 100.0 | % | |||||||||||||||||||||||||
Operating income as a percentage of sales | 6.2 | % | 2.4 | % | 0.9 | % | 2.3 | % | 3.7 | % |
13-Week Period Ended Apr. 1, 2023 | |||||||||||||||||||||||||||||||||||
U.S. Foodservice Operations | International Foodservice Operations | SYGMA | Other | Global Support Center |
Consolidated
Totals |
||||||||||||||||||||||||||||||
(In thousands) | |||||||||||||||||||||||||||||||||||
Sales | $ | 13,257,519 | $ | 3,344,121 | $ | 1,972,058 | $ | 301,978 | $ | — | $ | 18,875,676 | |||||||||||||||||||||||
Percentage of total | 70.2 | % | 17.7 | % | 10.4 | % | 1.7 | % | 100.0 | % | |||||||||||||||||||||||||
Operating income (loss) | $ | 857,023 | $ | 48,236 | $ | 25,618 | $ | 11,836 | $ | (246,986) | $ | 695,727 | |||||||||||||||||||||||
Percentage of total segments | 90.9 | % | 5.1 | % | 2.7 | % | 1.3 | % | 100.0 | % | |||||||||||||||||||||||||
Operating income as a percentage of sales | 6.5 | % | 1.4 | % | 1.3 | % | 3.9 | % | 3.7 | % |
39-Week Period Ended Mar. 30, 2024 | |||||||||||||||||||||||||||||||||||
U.S. Foodservice Operations | International Foodservice Operations | SYGMA | Other | Global Support Center |
Consolidated
Totals |
||||||||||||||||||||||||||||||
(In thousands) | |||||||||||||||||||||||||||||||||||
Sales | $ | 40,925,350 | $ | 10,772,900 | $ | 5,723,651 | $ | 865,995 | $ | — | $ | 58,287,896 | |||||||||||||||||||||||
Sales increase (decrease) | 2.5 | % | 8.7 | % | (2.0) | % | (4.8) | % | 3.0 | % | |||||||||||||||||||||||||
Percentage of total | 70.2 | % | 18.5 | % | 9.8 | % | 1.5 | % | 100.0 | % | |||||||||||||||||||||||||
Operating income (loss) | $ | 2,632,451 | $ | 260,311 | $ | 45,918 | $ | 26,581 | $ | (739,590) | $ | 2,225,671 | |||||||||||||||||||||||
Operating income (loss) increase (decrease) | 3.5 | % | 35.1 | % | 20.3 | % | (20.0) | % | 0.7 | % | 7.3 | % | |||||||||||||||||||||||
Percentage of total segments | 88.8 | % | 8.8 | % | 1.5 | % | 0.9 | % | 100.0 | % | |||||||||||||||||||||||||
Operating income as a percentage of sales | 6.4 | % | 2.4 | % | 0.8 | % | 3.1 | % | 3.8 | % |
39-Week Period Ended Apr. 1, 2023 | |||||||||||||||||||||||||||||||||||
U.S. Foodservice Operations | International Foodservice Operations | SYGMA | Other | Global Support Center |
Consolidated
Totals |
||||||||||||||||||||||||||||||
(In thousands) | |||||||||||||||||||||||||||||||||||
Sales | $ | 39,937,055 | $ | 9,910,267 | $ | 5,839,051 | $ | 910,086 | $ | — | $ | 56,596,459 | |||||||||||||||||||||||
Percentage of total | 70.6 | % | 17.5 | % | 10.3 | % | 1.6 | % | 100.0 | % | |||||||||||||||||||||||||
Operating income (loss) | $ | 2,543,704 | $ | 192,629 | $ | 38,161 | $ | 33,244 | $ | (734,387) | $ | 2,073,351 | |||||||||||||||||||||||
Percentage of total segments | 90.6 | % | 6.9 | % | 1.3 | % | 1.2 | % | 100.0 | % | |||||||||||||||||||||||||
Operating income as a percentage of sales | 6.4 | % | 1.9 | % | 0.6 | % | 3.7 | % | 3.7 | % |
13-Week Period Ended Mar. 30, 2024 | 13-Week Period Ended Apr. 1, 2023 | Change in Dollars | % Change | ||||||||||||||||||||
(Dollars in thousands) | |||||||||||||||||||||||
Sales | $ | 13,707,108 | $ | 13,257,519 | $ | 449,589 | 3.4 | % | |||||||||||||||
Gross profit | 2,652,847 | 2,545,859 | 106,988 | 4.2 | |||||||||||||||||||
Operating expenses | 1,800,403 | 1,688,836 | 111,567 | 6.6 | |||||||||||||||||||
Operating income | $ | 852,444 | $ | 857,023 | $ | (4,579) | (0.5) | % | |||||||||||||||
Gross profit | $ | 2,652,847 | $ | 2,545,859 | $ | 106,988 | 4.2 | % | |||||||||||||||
Adjusted operating expenses (Non-GAAP) | 1,778,055 | 1,677,133 | 100,922 | 6.0 | |||||||||||||||||||
Adjusted operating income (Non-GAAP) | $ | 874,792 | $ | 868,726 | $ | 6,066 | 0.7 | % | |||||||||||||||
39-Week Period Ended Mar. 30, 2024 | 39-Week Period Ended Apr. 1, 2023 | Change in Dollars | % Change | ||||||||||||||||||||
(Dollars in thousands) | |||||||||||||||||||||||
Sales | $ | 40,925,350 | $ | 39,937,055 | $ | 988,295 | 2.5 | % | |||||||||||||||
Gross profit | 7,915,316 | 7,651,291 | 264,025 | 3.5 | |||||||||||||||||||
Operating expenses | 5,282,865 | 5,107,587 | 175,278 | 3.4 | |||||||||||||||||||
Operating income | $ | 2,632,451 | $ | 2,543,704 | $ | 88,747 | 3.5 | % | |||||||||||||||
Gross profit | $ | 7,915,316 | $ | 7,651,291 | $ | 264,025 | 3.5 | % | |||||||||||||||
Adjusted operating expenses (Non-GAAP) | 5,235,824 | 5,075,991 | 159,833 | 3.1 | |||||||||||||||||||
Adjusted operating income (Non-GAAP) | $ | 2,679,492 | $ | 2,575,300 | $ | 104,192 | 4.0 | % |
Increase (Decrease) | Increase (Decrease) | ||||||||||||||||||||||
13-Week Period | 39-Week Period | ||||||||||||||||||||||
(Dollars in millions) | (Dollars in millions) | ||||||||||||||||||||||
Cause of change | Percentage | Dollars | Percentage | Dollars | |||||||||||||||||||
Case volume
(1)
|
2.6 | % | $ | 337.4 | 2.7 | % | $ | 1,045.4 | |||||||||||||||
Inflation | 1.3 | 171.8 | 0.1 | 33.5 | |||||||||||||||||||
Other
(2)
|
(0.5) | (59.6) | (0.3) | (90.6) | |||||||||||||||||||
Total change in sales | 3.4 | % | $ | 449.6 | 2.5 | % | $ | 988.3 | |||||||||||||||
(1) |
Case volumes increased 2.9% and 3.0% compared to the third quarter and first 39 weeks of fiscal 2023, respectively. This volume increase resulted in a 2.6% and 2.7% increase in the dollar value of sales compared to the third quarter and first 39 weeks of fiscal 2023, respectively. Our volume reporting includes case volumes attributable to Edward Don.
|
||||
(2)
|
Case volume reflects our broadline and specialty businesses, with the exception of our specialty meats business, which measures its volume in pounds. Any impact in volumes from these operations are included within “Other.”
|
13-Week Period Ended Mar. 30, 2024 | 13-Week Period Ended Apr. 1, 2023 | Change in Dollars | % Change | ||||||||||||||||||||
(Dollars in thousands) | |||||||||||||||||||||||
Sales | $ | 3,493,232 | $ | 3,344,121 | $ | 149,111 | 4.5 | % | |||||||||||||||
Gross profit | 719,681 | 642,778 | 76,903 | 12.0 | |||||||||||||||||||
Operating expenses | 635,783 | 594,542 | 41,241 | 6.9 | |||||||||||||||||||
Operating income | $ | 83,898 | $ | 48,236 | $ | 35,662 | 73.9 | % | |||||||||||||||
Gross profit | $ | 719,681 | $ | 642,778 | $ | 76,903 | 12.0 | % | |||||||||||||||
Adjusted operating expenses (Non-GAAP) | 610,322 | 575,845 | 34,477 | 6.0 | |||||||||||||||||||
Adjusted operating income (Non-GAAP) | $ | 109,359 | $ | 66,933 | $ | 42,426 | 63.4 | % | |||||||||||||||
Sales on a constant currency basis (Non-GAAP) | $ | 3,423,711 | $ | 3,344,121 | $ | 79,590 | 2.4 | % | |||||||||||||||
Gross profit on a constant currency basis (Non-GAAP) | 704,044 | 642,778 | 61,266 | 9.5 | |||||||||||||||||||
Adjusted operating expenses on a constant currency basis (Non-GAAP) | 596,681 | 575,845 | 20,836 | 3.6 | |||||||||||||||||||
Adjusted operating income on a constant currency basis (Non-GAAP) | $ | 107,363 | $ | 66,933 | $ | 40,430 | 60.4 | % | |||||||||||||||
39-Week Period Ended Mar. 30, 2024 | 39-Week Period Ended Apr. 1, 2023 | Change in Dollars | % Change | ||||||||||||||||||||
(Dollars in thousands) | |||||||||||||||||||||||
Sales | $ | 10,772,900 | $ | 9,910,267 | $ | 862,633 | 8.7 | % | |||||||||||||||
Gross profit | 2,159,820 | 1,916,503 | 243,317 | 12.7 | |||||||||||||||||||
Operating expenses | 1,899,509 | 1,723,874 | 175,635 | 10.2 | |||||||||||||||||||
Operating income | $ | 260,311 | $ | 192,629 | $ | 67,682 | 35.1 | % | |||||||||||||||
Gross profit | $ | 2,159,820 | $ | 1,916,503 | $ | 243,317 | 12.7 | % | |||||||||||||||
Adjusted operating expenses (Non-GAAP) | 1,831,898 | 1,663,998 | 167,900 | 10.1 | |||||||||||||||||||
Adjusted operating income (Non-GAAP) | $ | 327,922 | $ | 252,505 | $ | 75,417 | 29.9 | % | |||||||||||||||
Sales on a constant currency basis (Non-GAAP) | $ | 10,493,278 | $ | 9,910,267 | $ | 583,011 | 5.9 | % | |||||||||||||||
Gross profit on a constant currency basis (Non-GAAP) | 2,093,345 | 1,916,503 | 176,842 | 9.2 | |||||||||||||||||||
Adjusted operating expenses on a constant currency basis (Non-GAAP) | 1,770,514 | 1,663,998 | 106,516 | 6.4 | |||||||||||||||||||
Adjusted operating income on a constant currency basis (Non-GAAP) | $ | 322,831 | $ | 252,505 | $ | 70,326 | 27.9 | % |
Increase (Decrease) | Increase (Decrease) | ||||||||||||||||||||||
13-Week Period | 39-Week Period | ||||||||||||||||||||||
(Dollars in millions) | (Dollars in millions) | ||||||||||||||||||||||
Cause of change | Percentage | Dollars | Percentage | Dollars | |||||||||||||||||||
Inflation | 2.0 | % | $ | 67.4 | 4.4 | % | $ | 438.2 | |||||||||||||||
Foreign currency | 2.1 | 69.5 | 2.8 | 279.6 | |||||||||||||||||||
Other
(1)
|
0.4 | 12.2 | 1.5 | 144.8 | |||||||||||||||||||
Total change in sales | 4.5 | % | $ | 149.1 | 8.7 | % | $ | 862.6 | |||||||||||||||
(1)
|
The impact of volumes as a component of sales growth from international operations are included within “Other.”
|
The discussion of our results includes certain non-GAAP financial measures, including EBITDA and adjusted EBITDA, that we believe provide important perspective with respect to underlying business trends. Other than EBITDA and free cash flow, any non-GAAP financial measures will be denoted as adjusted measures to remove (1) restructuring charges; (2) expenses associated with our various transformation initiatives; (3) severance charges; and (4) acquisition-related costs consisting of: (a) intangible amortization expense and (b) acquisition costs and due diligence costs related to our acquisitions. Our results for fiscal 2023 were also impacted by adjustments to a product return allowance pertaining to COVID-related personal protection equipment inventory, a pension settlement charge that resulted from the purchase of a nonparticipating single premium group annuity contract that transferred defined benefit plan obligations to an insurer and the reduction of bad debt expense previously recognized in fiscal 2020 due to the impact of the COVID-19 pandemic on the collectability of our pre-pandemic trade receivable balances.
|
||
The results of our operations can be impacted due to changes in exchange rates applicable in converting local currencies to U.S. dollars. We measure our results on a constant currency basis. Constant currency operating results are calculated by translating current-period local currency operating results with the currency exchange rates used to translate the financial statements in the comparable prior-year period to determine what the current-period U.S. dollar operating results would have been if the currency exchange rate had not changed from the comparable prior-year period. | ||
Management believes that adjusting its operating expenses, operating income, net earnings and diluted earnings per share to remove these Certain Items and presenting its results on a constant currency basis provides an important perspective with respect to our underlying business trends and results. It provides meaningful supplemental information to both management and investors that (1) is indicative of the performance of the company’s underlying operations and (2) facilitates comparisons on a year-over-year basis. | ||
Sysco has a history of growth through acquisitions and excludes from its non-GAAP financial measures the impact of acquisition-related intangible amortization, acquisition costs and due diligence costs for those acquisitions. We believe this approach significantly enhances the comparability of Sysco’s results for fiscal year 2024 and fiscal year 2023. | ||
Set forth on the following page is a reconciliation of sales, operating expenses, operating income, other (income) expense, net earnings and diluted earnings per share to adjusted results for these measures for the periods presented. Individual components of diluted earnings per share may not be equal to the total presented when added due to rounding. Adjusted diluted earnings per share is calculated using adjusted net earnings divided by diluted shares outstanding. |
13-Week Period Ended Mar. 30, 2024 | 13-Week Period Ended Apr. 1, 2023 | Change in Dollars | %/bps Change | ||||||||||||||||||||
Sales (GAAP) | $ | 19,379,500 | $ | 18,875,676 | $ | 503,824 | 2.7 | % | |||||||||||||||
Impact of currency fluctuations
(1)
|
(69,576) | — | (69,576) | (0.4) | |||||||||||||||||||
Comparable sales using a constant currency basis (Non-GAAP) | $ | 19,309,924 | $ | 18,875,676 | $ | 434,248 | 2.3 | % | |||||||||||||||
Cost of sales (GAAP) | $ | 15,770,444 | $ | 15,444,316 | $ | 326,128 | 2.1 | % | |||||||||||||||
Gross profit (GAAP) | $ | 3,609,056 | $ | 3,431,360 | $ | 177,696 | 5.2 | % | |||||||||||||||
Impact of currency fluctuations
(1)
|
(15,662) | — | (15,662) | (0.5) | |||||||||||||||||||
Comparable gross profit adjusted for Certain Items using a constant currency basis (Non-GAAP) | $ | 3,593,394 | $ | 3,431,360 | $ | 162,034 | 4.7 | % | |||||||||||||||
Gross margin (GAAP) | 18.62 | % | 18.18 | % | 44 bps | ||||||||||||||||||
Impact of currency fluctuations
(1)
|
(0.01) | — | -1 bp | ||||||||||||||||||||
Comparable gross margin adjusted for Certain Items using a constant currency basis (Non-GAAP) | 18.61 | % | 18.18 | % | 43 bps | ||||||||||||||||||
Operating expenses (GAAP) | $ | 2,887,010 | $ | 2,735,633 | $ | 151,377 | 5.5 | % | |||||||||||||||
Impact of restructuring and transformational project costs
(2)
|
(28,472) | (12,255) | (16,217) | NM | |||||||||||||||||||
Impact of acquisition-related costs
(3)
|
(48,734) | (29,004) | (19,730) | (68.0) | |||||||||||||||||||
Impact of bad debt reserve adjustments
(4)
|
— | (90) | 90 | NM | |||||||||||||||||||
Operating expenses adjusted for Certain Items (Non-GAAP) | 2,809,804 | 2,694,284 | 115,520 | 4.3 | |||||||||||||||||||
Impact of currency fluctuations
(1)
|
(14,433) | — | (14,433) | (0.5) | |||||||||||||||||||
Comparable operating expenses adjusted for Certain Items using a constant currency basis (Non-GAAP) | $ | 2,795,371 | $ | 2,694,284 | $ | 101,087 | 3.8 | % | |||||||||||||||
Operating expense as a percentage of sales (GAAP) | 14.90 | % | 14.49 | % | 41 bps | ||||||||||||||||||
Impact of certain item adjustments | (0.40) | (0.22) | -18 bps | ||||||||||||||||||||
Adjusted operating expense as a percentage of sales (Non-GAAP) | 14.50 | % | 14.27 | % | 23 bps | ||||||||||||||||||
Operating income (GAAP) | $ | 722,046 | $ | 695,727 | $ | 26,319 | 3.8 | % | |||||||||||||||
Impact of restructuring and transformational project costs
(2)
|
28,472 | 12,255 | 16,217 | NM | |||||||||||||||||||
Impact of acquisition-related costs
(3)
|
48,734 | 29,004 | 19,730 | 68.0 | |||||||||||||||||||
Impact of bad debt reserve adjustments
(4)
|
— | 90 | (90) | NM | |||||||||||||||||||
Operating income adjusted for Certain Items (Non-GAAP) | 799,252 | 737,076 | 62,176 | 8.4 | |||||||||||||||||||
Impact of currency fluctuations
(1)
|
(1,229) | — | (1,229) | (0.1) | |||||||||||||||||||
Comparable operating income adjusted for Certain Items using a constant currency basis (Non-GAAP) | $ | 798,023 | $ | 737,076 | $ | 60,947 | 8.3 | % | |||||||||||||||
Operating margin (GAAP) | 3.73 | % | 3.69 | % | 4 bps | ||||||||||||||||||
Operating margin adjusted for Certain Items (Non-GAAP) | 4.12 | % | 3.90 | % | 22 bps | ||||||||||||||||||
Operating margin adjusted for Certain Items using a constant currency basis (Non-GAAP) | 4.13 | % | 3.90 | % | 23 bps | ||||||||||||||||||
Other expense (GAAP) | $ | 10,380 | $ | 6,759 | $ | 3,621 | 53.6 | % | |||||||||||||||
Impact of other non-routine gains and losses | — | (448) | 448 | NM | |||||||||||||||||||
Other expense adjusted for Certain Items (Non-GAAP) | $ | 10,380 | $ | 6,311 | $ | 4,069 | 64.5 | % | |||||||||||||||
Net earnings (GAAP) | $ | 424,688 | $ | 429,604 | $ | (4,916) | (1.1) | % | |||||||||||||||
13-Week Period Ended Mar. 30, 2024 | 13-Week Period Ended Apr. 1, 2023 | Change in Dollars | %/bps Change | ||||||||||||||||||||
Impact of restructuring and transformational project costs
(2)
|
28,472 | 12,255 | 16,217 | NM | |||||||||||||||||||
Impact of acquisition-related costs
(3)
|
48,734 | 29,004 | 19,730 | 68.0 | |||||||||||||||||||
Impact of bad debt reserve adjustments
(4)
|
— | 90 | (90) | NM | |||||||||||||||||||
Impact of other non-routine gains and losses | — | 448 | (448) | NM | |||||||||||||||||||
Tax impact of restructuring and transformational project costs
(5)
|
(6,826) | (3,190) | (3,636) | NM | |||||||||||||||||||
Tax impact of acquisition-related costs
(5)
|
(11,684) | (7,550) | (4,134) | (54.8) | |||||||||||||||||||
Tax impact of bad debt reserves adjustments
(5)
|
— | (23) | 23 | NM | |||||||||||||||||||
Tax impact of other non-routine gains and losses
(5)
|
— | (117) | 117 | NM | |||||||||||||||||||
Net earnings adjusted for Certain Items (Non-GAAP) | $ | 483,384 | $ | 460,521 | $ | 22,863 | 5.0 | % | |||||||||||||||
Diluted earnings per share (GAAP) | $ | 0.85 | $ | 0.84 | $ | 0.01 | 1.2 | % | |||||||||||||||
Impact of restructuring and transformational project costs
(2)
|
0.06 | 0.02 | 0.04 | NM | |||||||||||||||||||
Impact of acquisition-related costs
(3)
|
0.10 | 0.06 | 0.04 | 66.7 | |||||||||||||||||||
Tax impact of restructuring and transformational project costs
(5)
|
(0.01) | (0.01) | — | — | |||||||||||||||||||
Tax impact of acquisition-related costs
(5)
|
(0.02) | (0.01) | (0.01) | (100.0) | |||||||||||||||||||
Diluted earnings per share adjusted for Certain Items (Non-GAAP)
(6)
|
$ | 0.96 | $ | 0.90 | $ | 0.06 | 6.7 | % | |||||||||||||||
(1)
|
Represents a constant currency adjustment, which eliminates the impact of foreign currency fluctuations on the current year results.
|
||||
(2)
|
Fiscal 2024 includes $13 million related to restructuring and severance charges and $15 million related to various transformation initiative costs, primarily consisting of changes to our business technology strategy. Fiscal 2023 includes $2 million related to restructuring and severance charges and $10 million related to various transformation initiative costs, primarily consisting of changes to our business technology strategy.
|
||||
(3)
|
Fiscal 2024 includes $32 million of intangible amortization expense and $17 million in acquisition and due diligence costs. Fiscal 2023 includes $27 million of intangible amortization expense and $2 million in acquisition and due diligence costs.
|
||||
(4)
|
Fiscal 2023 represents the reduction of bad debt charges previously taken on pre-pandemic trade receivable balances in fiscal 2020. | ||||
(5)
|
The tax impact of adjustments for Certain Items are calculated by multiplying the pretax impact of each Certain Item by the statutory rates in effect for each jurisdiction where the Certain Item was incurred.
|
||||
(6)
|
Individual components of diluted earnings per share may not equal the total presented when added due to rounding. Total diluted earnings per share is calculated using adjusted net earnings divided by diluted shares outstanding. | ||||
NM | Represents that the percentage change is not meaningful. |
39-Week Period Ended Mar. 30, 2024 | 39-Week Period Ended Apr. 1, 2023 | Change in Dollars | %/bps Change | ||||||||||||||||||||
Sales (GAAP) | $ | 58,287,896 | $ | 56,596,459 | $ | 1,691,437 | 3.0 | % | |||||||||||||||
Impact of currency fluctuations
(1)
|
(278,400) | — | (278,400) | (0.5) | |||||||||||||||||||
Comparable sales using a constant currency basis (Non-GAAP) | $ | 58,009,496 | $ | 56,596,459 | $ | 1,413,037 | 2.5 | % | |||||||||||||||
Cost of sales (GAAP) | $ | 47,517,435 | $ | 46,326,628 | $ | 1,190,807 | 2.6 | % | |||||||||||||||
Impact of inventory valuation adjustment
(2)
|
— | 2,571 | (2,571) | — | |||||||||||||||||||
Cost of sales adjusted for Certain Items (Non-GAAP) | $ | 47,517,435 | $ | 46,329,199 | $ | 1,188,236 | 2.6 | % | |||||||||||||||
Gross profit (GAAP) | $ | 10,770,461 | $ | 10,269,831 | $ | 500,630 | 4.9 | % | |||||||||||||||
Impact of inventory valuation adjustment
(2)
|
— | (2,571) | 2,571 | — | |||||||||||||||||||
Gross profit adjusted for Certain Items (Non-GAAP) | 10,770,461 | 10,267,260 | 503,201 | 4.9 | |||||||||||||||||||
Impact of currency fluctuations
(1)
|
(66,029) | — | (66,029) | (0.6) | |||||||||||||||||||
Comparable gross profit adjusted for Certain Items using a constant currency basis (Non-GAAP) | $ | 10,704,432 | $ | 10,267,260 | $ | 437,172 | 4.3 | % | |||||||||||||||
Gross margin (GAAP) | 18.48 | % | 18.15 | % | 33 bps | ||||||||||||||||||
Impact of inventory valuation adjustment
(2)
|
— | (0.01) | 1 bp | ||||||||||||||||||||
Gross margin adjusted for Certain Items (Non-GAAP) | 18.48 | 18.14 | 34 bps | ||||||||||||||||||||
Impact of currency fluctuations
(1)
|
(0.03) | — | -3 bps | ||||||||||||||||||||
Comparable gross margin adjusted for Certain Items using a constant currency basis (Non-GAAP) | 18.45 | % | 18.14 | % | 31 bps | ||||||||||||||||||
Operating expenses (GAAP) | $ | 8,544,790 | $ | 8,196,480 | $ | 348,310 | 4.2 | % | |||||||||||||||
Impact of restructuring and transformational project costs
(3)
|
(59,567) | (38,288) | (21,279) | (55.6) | |||||||||||||||||||
Impact of acquisition-related costs
(4)
|
(113,193) | (87,419) | (25,774) | (29.5) | |||||||||||||||||||
Impact of bad debt reserve adjustments
(5)
|
— | 4,425 | (4,425) | NM | |||||||||||||||||||
Operating expenses adjusted for Certain Items (Non-GAAP) | 8,372,030 | 8,075,198 | 296,832 | 3.7 | |||||||||||||||||||
Impact of currency fluctuations
(1)
|
(63,371) | — | (63,371) | (0.8) | |||||||||||||||||||
Comparable operating expenses adjusted for Certain Items using a constant currency basis (Non-GAAP) | $ | 8,308,659 | $ | 8,075,198 | $ | 233,461 | 2.9 | % | |||||||||||||||
Operating expense as a percentage of sales (GAAP) | 14.66 | % | 14.48 | % | 18 bps | ||||||||||||||||||
Impact of certain item adjustments | (0.30) | (0.21) | -9 bps | ||||||||||||||||||||
Adjusted operating expense as a percentage of sales (Non-GAAP) | 14.36 | % | 14.27 | % | 9 bps | ||||||||||||||||||
Operating income (GAAP) | $ | 2,225,671 | $ | 2,073,351 | $ | 152,320 | 7.3 | % | |||||||||||||||
Impact of inventory valuation adjustment
(2)
|
— | (2,571) | 2,571 | NM | |||||||||||||||||||
Impact of restructuring and transformational project costs
(3)
|
59,567 | 38,288 | 21,279 | 55.6 | |||||||||||||||||||
Impact of acquisition-related costs
(4)
|
113,193 | 87,419 | 25,774 | 29.5 | |||||||||||||||||||
Impact of bad debt reserve adjustments
(5)
|
— | (4,425) | 4,425 | NM | |||||||||||||||||||
Operating income adjusted for Certain Items (Non-GAAP) | 2,398,431 | 2,192,062 | 206,369 | 9.4 | |||||||||||||||||||
Impact of currency fluctuations
(1)
|
(2,658) | — | (2,658) | (0.1) | |||||||||||||||||||
Comparable operating income adjusted for Certain Items using a constant currency basis (Non-GAAP) | $ | 2,395,773 | $ | 2,192,062 | $ | 203,711 | 9.3 | % | |||||||||||||||
39-Week Period Ended Mar. 30, 2024 | 39-Week Period Ended Apr. 1, 2023 | Change in Dollars | %/bps Change | ||||||||||||||||||||
Other expense (GAAP) | $ | 22,265 | $ | 354,813 | $ | (332,548) | (93.7) | % | |||||||||||||||
Impact of other non-routine gains and losses
(6)
|
— | (315,326) | 315,326 | NM | |||||||||||||||||||
Other expense adjusted for Certain Items (Non-GAAP) | $ | 22,265 | $ | 39,487 | $ | (17,222) | (43.6) | % | |||||||||||||||
Net earnings (GAAP) | $ | 1,343,322 | $ | 1,036,388 | $ | 306,934 | 29.6 | % | |||||||||||||||
Impact of inventory valuation adjustment
(2)
|
— | (2,571) | 2,571 | NM | |||||||||||||||||||
Impact of restructuring and transformational project costs
(3)
|
59,567 | 38,288 | 21,279 | 55.6 | |||||||||||||||||||
Impact of acquisition-related costs
(4)
|
113,193 | 87,419 | 25,774 | 29.5 | |||||||||||||||||||
Impact of bad debt reserve adjustments
(5)
|
— | (4,425) | 4,425 | NM | |||||||||||||||||||
Impact of other non-routine gains and losses
(6)
|
— | 315,326 | (315,326) | NM | |||||||||||||||||||
Tax impact of inventory valuation adjustment
(7)
|
— | 648 | (648) | NM | |||||||||||||||||||
Tax impact of restructuring and transformational project costs
(7)
|
(14,510) | (9,649) | (4,861) | (50.4) | |||||||||||||||||||
Tax impact of acquisition-related costs
(7)
|
(27,572) | (22,031) | (5,541) | (25.2) | |||||||||||||||||||
Tax impact of bad debt reserves adjustments
(7)
|
— | 1,115 | (1,115) | NM | |||||||||||||||||||
Tax impact of other non-routine gains and losses
(7)
|
— | (79,466) | 79,466 | NM | |||||||||||||||||||
Net earnings adjusted for Certain Items (Non-GAAP) | $ | 1,474,000 | $ | 1,361,042 | $ | 112,958 | 8.3 | % | |||||||||||||||
Diluted earnings per share (GAAP) | $ | 2.66 | $ | 2.03 | $ | 0.63 | 31.0 | % | |||||||||||||||
Impact of inventory valuation adjustment
(2)
|
— | (0.01) | 0.01 | NM | |||||||||||||||||||
Impact of restructuring and transformational project costs
(3)
|
0.12 | 0.08 | 0.04 | 50.0 | |||||||||||||||||||
Impact of acquisition-related costs
(4)
|
0.22 | 0.17 | 0.05 | 29.4 | |||||||||||||||||||
Impact of bad debt reserve adjustments
(5)
|
— | (0.01) | 0.01 | NM | |||||||||||||||||||
Impact of other non-routine gains and losses
(6)
|
— | 0.62 | (0.62) | NM | |||||||||||||||||||
Tax impact of restructuring and transformational project costs
(7)
|
(0.03) | (0.02) | (0.01) | (50.0) | |||||||||||||||||||
Tax impact of acquisition-related costs
(7)
|
(0.05) | (0.04) | (0.01) | (25.0) | |||||||||||||||||||
Tax impact of other non-routine gains and losses
(7)
|
— | (0.16) | 0.16 | NM | |||||||||||||||||||
Diluted earnings per share adjusted for Certain Items (Non-GAAP)
(8)
|
$ | 2.92 | $ | 2.67 | $ | 0.25 | 9.4 | % |
(1)
|
Represents a constant currency adjustment which eliminates the impact of foreign currency fluctuations on the current year results.
|
||||
(2)
|
Fiscal 2023 represents an adjustment to a product return allowance related to COVID-related personal protection equipment inventory. | ||||
(3)
|
Fiscal 2024 includes $22 million related to restructuring and severance charges and $38 million related to various transformation initiative costs, primarily consisting of changes to our business technology strategy. Fiscal 2023 includes $12 million related to restructuring and severance charges and $26 million related to various transformation initiative costs, primarily consisting of changes to our business technology strategy. | ||||
(4)
|
Fiscal 2024 includes $91 million of intangible amortization expense and $22 million in acquisition and due diligence costs. Fiscal 2023 includes $78 million of intangible amortization expense and $9 million in acquisition and due diligence costs.
|
||||
(5)
|
Fiscal 2023 represents the reduction of bad debt charges previously taken on pre-pandemic trade receivable balances in fiscal 2020.
|
||||
(6)
|
Fiscal 2023 primarily includes a pension settlement charge of $315 million that resulted from the purchase of a nonparticipating single premium group annuity contract that transferred defined benefit plan obligations to an insurer.
|
||||
(7)
|
The tax impact of adjustments for Certain Items is calculated by multiplying the pretax impact of each Certain Item by the statutory rates in effect for each jurisdiction where the Certain Item was incurred.
|
||||
(8)
|
Individual components of diluted earnings per share may not add up to the total presented due to rounding. Total diluted earnings per share is calculated using adjusted net earnings divided by diluted shares outstanding.
|
||||
NM | Represents that the percentage change is not meaningful. |
13-Week Period Ended Mar. 30, 2024 | 13-Week Period Ended Apr. 1, 2023 | Change in Dollars | %/bps Change | ||||||||||||||||||||
U.S. FOODSERVICE OPERATIONS | |||||||||||||||||||||||
Operating expenses (GAAP) | $ | 1,800,403 | $ | 1,688,836 | $ | 111,567 | 6.6 | % | |||||||||||||||
Impact of restructuring and transformational project costs
(1)
|
(6,134) | (159) | (5,975) | NM | |||||||||||||||||||
Impact of acquisition-related costs
(2)
|
(16,214) | (11,463) | (4,751) | (41.4) | |||||||||||||||||||
Impact of bad debt reserve adjustments
(3)
|
— | (81) | 81 | NM | |||||||||||||||||||
Operating expenses adjusted for Certain Items (Non-GAAP) | $ | 1,778,055 | $ | 1,677,133 | $ | 100,922 | 6.0 | % | |||||||||||||||
Operating income (GAAP) | $ | 852,444 | $ | 857,023 | $ | (4,579) | (0.5) | % | |||||||||||||||
Impact of restructuring and transformational project costs
(1)
|
6,134 | 159 | 5,975 | NM | |||||||||||||||||||
Impact of acquisition-related costs
(2)
|
16,214 | 11,463 | 4,751 | 41.4 | |||||||||||||||||||
Impact of bad debt reserve adjustments
(3)
|
— | 81 | (81) | NM | |||||||||||||||||||
Operating income adjusted for Certain Items (Non-GAAP) | $ | 874,792 | $ | 868,726 | $ | 6,066 | 0.7 | % | |||||||||||||||
INTERNATIONAL FOODSERVICE OPERATIONS | |||||||||||||||||||||||
Sales (GAAP) | $ | 3,493,232 | $ | 3,344,121 | $ | 149,111 | 4.5 | % | |||||||||||||||
Impact of currency fluctuations
(4)
|
(69,521) | — | (69,521) | (2.1) | |||||||||||||||||||
Comparable sales using a constant currency basis (Non-GAAP) | $ | 3,423,711 | $ | 3,344,121 | $ | 79,590 | 2.4 | % | |||||||||||||||
Gross profit (GAAP) | $ | 719,681 | $ | 642,778 | $ | 76,903 | 12.0 | % | |||||||||||||||
Impact of currency fluctuations
(4)
|
(15,637) | — | (15,637) | (2.5) | |||||||||||||||||||
Comparable gross profit using a constant currency basis (Non-GAAP) | $ | 704,044 | $ | 642,778 | $ | 61,266 | 9.5 | % | |||||||||||||||
Gross margin (GAAP) | 20.60 | % | 19.22 | % | 138 bps | ||||||||||||||||||
Impact of currency fluctuations
(4)
|
(0.04) | — | -4 bps | ||||||||||||||||||||
Comparable gross margin using a constant currency basis (Non-GAAP) | 20.56 | % | 19.22 | % | 134 bps | ||||||||||||||||||
Operating expenses (GAAP) | $ | 635,783 | $ | 594,542 | $ | 41,241 | 6.9 | % | |||||||||||||||
Impact of restructuring and transformational project costs
(5)
|
(6,775) | (2,103) | (4,672) | NM | |||||||||||||||||||
Impact of acquisition-related costs
(6)
|
(18,686) | (16,585) | (2,101) | (12.7) | |||||||||||||||||||
Impact of bad debt reserve adjustments
(3)
|
— | (9) | 9 | NM | |||||||||||||||||||
Operating expenses adjusted for Certain Items (Non-GAAP) | 610,322 | 575,845 | 34,477 | 6.0 | |||||||||||||||||||
Impact of currency fluctuations
(4)
|
(13,641) | — | (13,641) | (2.4) | |||||||||||||||||||
Comparable operating expenses adjusted for Certain Items using a constant currency basis (Non-GAAP) | $ | 596,681 | $ | 575,845 | $ | 20,836 | 3.6 | % | |||||||||||||||
Operating income (GAAP) | $ | 83,898 | $ | 48,236 | $ | 35,662 | 73.9 | % | |||||||||||||||
Impact of restructuring and transformational project costs
(5)
|
6,775 | 2,103 | 4,672 | NM | |||||||||||||||||||
Impact of acquisition-related costs
(6)
|
18,686 | 16,585 | 2,101 | 12.7 | |||||||||||||||||||
Impact of bad debt reserve adjustments
(3)
|
— | 9 | (9) | NM | |||||||||||||||||||
Operating income adjusted for Certain Items (Non-GAAP) | 109,359 | 66,933 | 42,426 | 63.4 | |||||||||||||||||||
Impact of currency fluctuations
(4)
|
(1,996) | — | (1,996) | (3.0) | |||||||||||||||||||
Comparable operating income adjusted for Certain Items using a constant currency basis (Non-GAAP) | $ | 107,363 | $ | 66,933 | $ | 40,430 | 60.4 | % | |||||||||||||||
SYGMA | |||||||||||||||||||||||
Operating expenses (GAAP) | $ | 136,453 | $ | 140,486 | $ | (4,033) | (2.9) | % | |||||||||||||||
Operating income (GAAP) | 16,805 | 25,618 | (8,813) | (34.4) | |||||||||||||||||||
OTHER | |||||||||||||||||||||||
Operating expenses (GAAP) | $ | 64,659 | $ | 67,615 | $ | (2,956) | (4.4) | % | |||||||||||||||
Operating income (GAAP) | 6,371 | 11,836 | (5,465) | (46.2) | |||||||||||||||||||
13-Week Period Ended Mar. 30, 2024 | 13-Week Period Ended Apr. 1, 2023 | Change in Dollars | %/bps Change | ||||||||||||||||||||
GLOBAL SUPPORT CENTER | |||||||||||||||||||||||
Gross profit (loss) (GAAP) | $ | 12,240 | $ | (2,832) | $ | 15,072 | NM | ||||||||||||||||
Operating expenses (GAAP) | $ | 249,712 | $ | 244,154 | $ | 5,558 | 2.3 | % | |||||||||||||||
Impact of restructuring and transformational project costs
(7)
|
(15,563) | (9,993) | (5,570) | (55.7) | |||||||||||||||||||
Impact of acquisition-related costs
(8)
|
(13,834) | (956) | (12,878) | NM | |||||||||||||||||||
Operating expenses adjusted for Certain Items (Non-GAAP) | $ | 220,315 | $ | 233,205 | $ | (12,890) | (5.5) | % | |||||||||||||||
Operating loss (GAAP) | $ | (237,472) | $ | (246,986) | $ | 9,514 | 3.9 | % | |||||||||||||||
Impact of restructuring and transformational project costs
(7)
|
15,563 | 9,993 | 5,570 | 55.7 | |||||||||||||||||||
Impact of acquisition-related costs
(8)
|
13,834 | 956 | 12,878 | NM | |||||||||||||||||||
Operating loss adjusted for Certain Items (Non-GAAP) | $ | (208,075) | $ | (236,037) | $ | 27,962 | 11.8 | % | |||||||||||||||
(1)
|
Primarily represents severance and transformation initiative costs. | ||||
(2)
|
Fiscal 2024 and fiscal 2023 include intangible amortization expense and acquisition costs.
|
||||
(3)
|
Fiscal 2023 represents the reduction of bad debt charges previously taken on pre-pandemic trade receivable balances in fiscal 2020.
|
||||
(4)
|
Represents a constant currency adjustment, which eliminates the impact of foreign currency fluctuations on current year results. | ||||
(5)
|
Includes restructuring costs primarily in Europe. | ||||
(6)
|
Represents intangible amortization expense.
|
||||
(7)
|
Includes various transformation initiative costs, primarily consisting of changes to our business technology strategy. | ||||
(8)
|
Represents due diligence costs. | ||||
NM | Represents that the percentage change is not meaningful. |
39-Week Period Ended Mar. 30, 2024 | 39-Week Period Ended Apr. 1, 2023 | Change in Dollars | %/bps Change | ||||||||||||||||||||
U.S. FOODSERVICE OPERATIONS | |||||||||||||||||||||||
Operating expenses (GAAP) | $ | 5,282,865 | $ | 5,107,587 | $ | 175,278 | 3.4 | % | |||||||||||||||
Impact of restructuring and transformational project costs
(1)
|
(6,361) | (203) | (6,158) | NM | |||||||||||||||||||
Impact of acquisition-related costs
(2)
|
(40,680) | (35,563) | (5,117) | (14.4) | |||||||||||||||||||
Impact of bad debt reserve adjustments
(3)
|
— | 4,170 | (4,170) | NM | |||||||||||||||||||
Operating expenses adjusted for Certain Items (Non-GAAP) | $ | 5,235,824 | $ | 5,075,991 | $ | 159,833 | 3.1 | % | |||||||||||||||
Operating income (GAAP) | $ | 2,632,451 | $ | 2,543,704 | $ | 88,747 | 3.5 | % | |||||||||||||||
Impact of restructuring and transformational project costs
(1)
|
6,361 | 203 | 6,158 | NM | |||||||||||||||||||
Impact of acquisition-related costs
(2)
|
40,680 | 35,563 | 5,117 | 14.4 | |||||||||||||||||||
Impact of bad debt reserve adjustments
(3)
|
— | (4,170) | 4,170 | NM | |||||||||||||||||||
Operating income adjusted for Certain Items (Non-GAAP) | $ | 2,679,492 | $ | 2,575,300 | $ | 104,192 | 4.0 | % | |||||||||||||||
INTERNATIONAL FOODSERVICE OPERATIONS | |||||||||||||||||||||||
Sales (GAAP) | $ | 10,772,900 | $ | 9,910,267 | $ | 862,633 | 8.7 | % | |||||||||||||||
Impact of currency fluctuations
(4)
|
(279,622) | — | (279,622) | (2.8) | |||||||||||||||||||
Comparable sales using a constant currency basis (Non-GAAP) | $ | 10,493,278 | $ | 9,910,267 | $ | 583,011 | 5.9 | % | |||||||||||||||
Gross profit (GAAP) | $ | 2,159,820 | $ | 1,916,503 | $ | 243,317 | 12.7 | % | |||||||||||||||
Impact of currency fluctuations
(4)
|
(66,475) | — | (66,475) | (3.5) | |||||||||||||||||||
Comparable gross profit using a constant currency basis (Non-GAAP) | $ | 2,093,345 | $ | 1,916,503 | $ | 176,842 | 9.2 | % | |||||||||||||||
Gross margin (GAAP) | 20.05 | % | 19.34 | % | 71 bps | ||||||||||||||||||
Impact of currency fluctuations
(4)
|
(0.10) | — | -10 bps | ||||||||||||||||||||
Comparable gross margin using a constant currency basis (Non-GAAP) | 19.95 | % | 19.34 | % | 61 bps | ||||||||||||||||||
Operating expenses (GAAP) | $ | 1,899,509 | $ | 1,723,874 | $ | 175,635 | 10.2 | % | |||||||||||||||
Impact of restructuring and transformational project costs
(5)
|
(15,181) | (11,597) | (3,584) | (30.9) | |||||||||||||||||||
Impact of acquisition-related costs
(6)
|
(52,430) | (48,534) | (3,896) | (8.0) | |||||||||||||||||||
Impact of bad debt reserve adjustments
(3)
|
— | 255 | (255) | NM | |||||||||||||||||||
Operating expenses adjusted for Certain Items (Non-GAAP) | 1,831,898 | 1,663,998 | 167,900 | 10.1 | |||||||||||||||||||
Impact of currency fluctuations
(4)
|
(61,384) | — | (61,384) | (3.7) | |||||||||||||||||||
Comparable operating expenses adjusted for Certain Items using a constant currency basis (Non-GAAP) | $ | 1,770,514 | $ | 1,663,998 | $ | 106,516 | 6.4 | % | |||||||||||||||
Operating income (GAAP) | $ | 260,311 | $ | 192,629 | $ | 67,682 | 35.1 | % | |||||||||||||||
Impact of restructuring and transformational project costs
(5)
|
15,181 | 11,597 | 3,584 | 30.9 | |||||||||||||||||||
Impact of acquisition-related costs
(6)
|
52,430 | 48,534 | 3,896 | 8.0 | |||||||||||||||||||
Impact of bad debt reserve adjustments
(3)
|
— | (255) | 255 | NM | |||||||||||||||||||
Operating income adjusted for Certain Items (Non-GAAP) | 327,922 | 252,505 | 75,417 | 29.9 | |||||||||||||||||||
Impact of currency fluctuations
(4)
|
(5,091) | — | (5,091) | (2.0) | |||||||||||||||||||
Comparable operating income adjusted for Certain Items using a constant currency basis (Non-GAAP) | $ | 322,831 | $ | 252,505 | $ | 70,326 | 27.9 | % | |||||||||||||||
39-Week Period Ended Mar. 30, 2024 | 39-Week Period Ended Apr. 1, 2023 | Change in Dollars | %/bps Change | ||||||||||||||||||||
SYGMA | |||||||||||||||||||||||
Sales (GAAP) | $ | 5,723,651 | $ | 5,839,051 | $ | (115,400) | (2.0) | % | |||||||||||||||
Gross profit (GAAP) | 454,575 | 470,458 | (15,883) | (3.4) | |||||||||||||||||||
Gross margin (GAAP) | 7.94 | % | 8.06 | % | -12 bps | ||||||||||||||||||
Operating expenses (GAAP) | $ | 408,657 | $ | 432,297 | $ | (23,640) | (5.5) | % | |||||||||||||||
Operating income (GAAP) | 45,918 | 38,161 | 7,757 | 20.3 | % | ||||||||||||||||||
OTHER | |||||||||||||||||||||||
Operating expenses (GAAP) | $ | 195,431 | $ | 204,356 | $ | (8,925) | (4.4) | % | |||||||||||||||
Operating income (GAAP) | 26,581 | 33,244 | (6,663) | (20.0) | % | ||||||||||||||||||
GLOBAL SUPPORT CENTER | |||||||||||||||||||||||
Gross profit (loss) (GAAP) | $ | 18,738 | $ | (6,021) | $ | 24,759 | NM | ||||||||||||||||
Impact of inventory valuation adjustment
(7)
|
— | (2,571) | 2,571 | NM | |||||||||||||||||||
Comparable gross profit (loss) adjusted for Certain Items (Non-GAAP) | $ | 18,738 | $ | (8,592) | $ | 27,330 | NM | ||||||||||||||||
Operating expenses (GAAP) | $ | 758,328 | $ | 728,366 | $ | 29,962 | 4.1 | % | |||||||||||||||
Impact of restructuring and transformational project costs
(8)
|
(38,025) | (26,488) | (11,537) | (43.6) | |||||||||||||||||||
Impact of acquisition-related costs
(9)
|
(20,083) | (3,322) | (16,761) | NM | |||||||||||||||||||
Operating expenses adjusted for Certain Items (Non-GAAP) | $ | 700,220 | $ | 698,556 | $ | 1,664 | 0.2 | % | |||||||||||||||
Operating loss (GAAP) | $ | (739,590) | $ | (734,387) | $ | (5,203) | (0.7) | % | |||||||||||||||
Impact of inventory valuation adjustment
(7)
|
— | (2,571) | 2,571 | NM | |||||||||||||||||||
Impact of restructuring and transformational project costs
(8)
|
38,025 | 26,488 | 11,537 | 43.6 | |||||||||||||||||||
Impact of acquisition-related costs
(9)
|
20,083 | 3,322 | 16,761 | NM | |||||||||||||||||||
Operating loss adjusted for Certain Items (Non-GAAP) | $ | (681,482) | $ | (707,148) | $ | 25,666 | 3.6 | % | |||||||||||||||
(1)
|
Primarily represents severance and transformation costs. | ||||
(2)
|
Includes intangible amortization expense and acquisition costs. | ||||
(3)
|
Fiscal 2023 represents the reduction of bad debt charges previously taken on pre-pandemic trade receivable balances in fiscal 2020.
|
||||
(4)
|
Represents a constant currency adjustment, which eliminates the impact of foreign currency fluctuations on current year results.
|
||||
(5)
|
Includes restructuring and severance costs, primarily in Europe.
|
||||
(6)
|
Represents intangible amortization expense.
|
||||
(7)
|
Fiscal 2023 represents an adjustment to a product return allowance related to COVID-related personal protection equipment inventory. | ||||
(8)
|
Includes various transformation initiative costs, primarily consisting of changes to our business technology strategy.
|
||||
(9)
|
Represents due diligence costs.
|
||||
NM | Represents that the percentage change is not meaningful. |
13-Week Period Ended Mar. 30, 2024 | 13-Week Period Ended Apr. 1, 2023 | Change in Dollars | % Change | ||||||||||||||||||||
Net earnings (GAAP) | $ | 424,688 | $ | 429,604 | $ | (4,916) | (1.1) | % | |||||||||||||||
Interest (GAAP) | 157,853 | 134,931 | 22,922 | 17.0 | |||||||||||||||||||
Income taxes (GAAP) | 129,125 | 124,433 | 4,692 | 3.8 | |||||||||||||||||||
Depreciation and amortization (GAAP) | 221,383 | 195,996 | 25,387 | 13.0 | |||||||||||||||||||
EBITDA (Non-GAAP) | $ | 933,049 | $ | 884,964 | $ | 48,085 | 5.4 | % | |||||||||||||||
Certain Item adjustments: | |||||||||||||||||||||||
Impact of restructuring and transformational project costs
(1)
|
$ | 26,538 | $ | 11,890 | $ | 14,648 | NM | ||||||||||||||||
Impact of acquisition-related costs
(2)
|
17,008 | 2,349 | 14,659 | NM | |||||||||||||||||||
Impact of bad debt reserve adjustments
(3)
|
— | 90 | (90) | NM | |||||||||||||||||||
Impact of other non-routine gains and losses | — | 448 | (448) | NM | |||||||||||||||||||
EBITDA adjusted for Certain Items (Non-GAAP)
(4)
|
$ | 976,595 | $ | 899,741 | $ | 76,854 | 8.5 | % | |||||||||||||||
Other expense (income), net, as adjusted (Non-GAAP)
(5)
|
10,380 | 6,311 | 4,069 | 64.5 | |||||||||||||||||||
Depreciation and amortization, as adjusted (Non-GAAP)
(6)
|
(187,723) | (168,976) | (18,747) | (11.1) | |||||||||||||||||||
Operating income adjusted for Certain Items (Non-GAAP) | $ | 799,252 | $ | 737,076 | $ | 62,176 | 8.4 | % |
(1)
|
Fiscal 2024 and fiscal 2023 include charges related to restructuring and severance, as well as various transformation initiative costs, primarily consisting of changes to our business technology strategy, excluding charges related to accelerated depreciation.
|
||||
(2)
|
Fiscal 2024 and fiscal 2023 include acquisition and due diligence costs. | ||||
(3)
|
Fiscal 2023 represents the reduction of bad debt charges previously taken on pre-pandemic trade receivable balances in fiscal 2020. | ||||
(4)
|
In arriving at adjusted EBITDA, Sysco does not adjust out interest income of $7 million and $7 million or non-cash stock compensation expense of $24 million and $21 million in fiscal 2024 and fiscal 2023, respectively.
|
||||
(5)
|
Fiscal 2024 and Fiscal 2023 primarily represent $10 million and $7 million, respectively, in GAAP other expense (income), net. | ||||
(6)
|
Fiscal 2024 includes $221 million in GAAP depreciation and amortization expense, less $34 million of Non-GAAP depreciation and amortization expense primarily related to acquisitions. Fiscal 2023 includes $196 million in GAAP depreciation and amortization expense, less $27 million of Non-GAAP depreciation and amortization expense primarily related to acquisitions. | ||||
NM | Represents that the percentage change is not meaningful. |
39-Week Period Ended Mar. 30, 2024 | 39-Week Period Ended Apr. 1, 2023 | Change in Dollars | % Change | ||||||||||||||||||||
Net earnings (GAAP) | $ | 1,343,322 | $ | 1,036,388 | $ | 306,934 | 29.6 | % | |||||||||||||||
Interest (GAAP) | 441,867 | 391,123 | 50,744 | 13.0 | |||||||||||||||||||
Income taxes (GAAP) | 418,217 | 291,027 | 127,190 | 43.7 | |||||||||||||||||||
Depreciation and amortization (GAAP) | 646,848 | 574,945 | 71,903 | 12.5 | |||||||||||||||||||
EBITDA (Non-GAAP) | $ | 2,850,254 | $ | 2,293,483 | $ | 556,771 | 24.3 | % | |||||||||||||||
Certain Item adjustments: | |||||||||||||||||||||||
Impact of inventory valuation adjustment
(1)
|
$ | — | $ | (2,571) | $ | 2,571 | NM | ||||||||||||||||
Impact of restructuring and transformational project costs
(2)
|
56,387 | 37,192 | 19,195 | 51.6 | |||||||||||||||||||
Impact of acquisition-related costs
(3)
|
21,862 | 8,944 | 12,918 | NM | |||||||||||||||||||
Impact of bad debt reserve adjustments
(4)
|
— | (4,425) | 4,425 | NM | |||||||||||||||||||
Impact of other non-routine gains and losses
(5)
|
— | 315,326 | (315,326) | NM | |||||||||||||||||||
EBITDA adjusted for Certain Items (Non-GAAP)
(6)
|
$ | 2,928,503 | $ | 2,647,949 | $ | 280,554 | 10.6 | % | |||||||||||||||
Other expense (income), net, as adjusted (Non-GAAP)
(7)
|
22,265 | 39,487 | (17,222) | (43.6) | |||||||||||||||||||
Depreciation and amortization, as adjusted (Non-GAAP)
(8)
|
(552,337) | (495,374) | (56,963) | (11.5) | |||||||||||||||||||
Operating income adjusted for Certain Items (Non-GAAP) | $ | 2,398,431 | $ | 2,192,062 | $ | 206,369 | 9.4 | % |
(1)
|
Fiscal 2023 represents an adjustment to a product return allowance related to COVID-related personal protection equipment inventory. | ||||
(2)
|
Fiscal 2024 and 2023 include charges related to restructuring and severance, as well as various transformation initiative costs, primarily consisting of changes to our business technology strategy and exclude charges related to accelerated depreciation.
|
||||
(3)
|
Fiscal 2024 and 2023 include acquisition and due diligence costs. | ||||
(4)
|
Fiscal 2023 represents the reduction of bad debt charges previously taken on pre-pandemic trade receivable balances in fiscal 2020. | ||||
(5)
|
Fiscal 2023 primarily represents a pension settlement charge of $315 million that resulted from the purchase of a nonparticipating single premium group annuity contract that transferred defined benefit plan obligations to an insurer.
|
||||
(6)
|
In arriving at adjusted EBITDA, Sysco does not exclude interest income of $28 million and $15 million or non-cash stock compensation expense of $77 million and $73 million for fiscal 2024 and fiscal 2023, respectively. | ||||
(7)
|
Fiscal 2024 represents $22 million in GAAP other expense (income), net. Fiscal 2023 represents $355 million in GAAP other expense (income), net less $315 million due to the certain items impact of a pension settlement charge that resulted from the purchase of a nonparticipating single premium group annuity contract that transferred defined benefit plan obligations to an insurer. | ||||
(8)
|
Fiscal 2024 includes $647 million in GAAP depreciation and amortization expense, less $95 million of Non-GAAP depreciation and amortization expense primarily related to acquisitions. Fiscal 2023 includes $575 million in GAAP depreciation and amortization expense, less $80 million of Non-GAAP depreciation and amortization expense primarily related to acquisitions. | ||||
NM | Represents that the percentage change is not meaningful. |
39-Week Period Ended Mar. 30, 2024 | 39-Week Period Ended Apr. 1, 2023 | ||||||||||
Source of cash (use of cash) | (In thousands) | ||||||||||
Net cash provided by operating activities (GAAP) | $ | 1,373,193 | $ | 1,425,782 | |||||||
Additions to plant and equipment | (530,161) | (474,456) | |||||||||
Proceeds from sales of plant and equipment | 20,708 | 28,313 | |||||||||
Free Cash Flow (Non-GAAP)
(1)
|
$ | 863,740 | $ | 979,639 | |||||||
Acquisition of businesses, net of cash acquired | $ | (1,181,188) | $ | (37,384) | |||||||
Debt borrowings (repayments), net | 1,447,080 | 92,917 | |||||||||
Stock repurchases | (699,947) | (377,800) | |||||||||
Dividends paid | (758,128) | (747,378) | |||||||||
(1)
|
Free cash flow should not be used as a substitute for the most comparable GAAP measure in assessing the company’s liquidity for the periods presented. An analysis of any non-GAAP financial measure should be used in conjunction with results presented in accordance with GAAP. See Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Key Performance Indicators” contained in our fiscal 2023 Form 10-K for discussions regarding this non-GAAP performance metric.
|
Combined Parent and Guarantor Subsidiaries Summarized Balance Sheet | Mar. 30, 2024 | Jul. 1, 2023 | ||||||||||||
(In thousands) | ||||||||||||||
ASSETS | ||||||||||||||
Receivables due from non-obligor subsidiaries | $ | 146,269 | $ | 321,476 | ||||||||||
Current assets | 5,664,978 | 5,149,509 | ||||||||||||
Total current assets | $ | 5,811,247 | $ | 5,470,985 | ||||||||||
Notes receivable from non-obligor subsidiaries | $ | 80,073 | $ | 108,380 | ||||||||||
Other noncurrent assets | 4,526,246 | 4,254,145 | ||||||||||||
Total noncurrent assets | $ | 4,606,319 | $ | 4,362,525 | ||||||||||
LIABILITIES | ||||||||||||||
Payables due to non-obligor subsidiaries | $ | 242,319 | $ | 71,175 | ||||||||||
Other current liabilities | 2,043,444 | 2,305,435 | ||||||||||||
Total current liabilities | $ | 2,285,763 | $ | 2,376,610 | ||||||||||
Notes payable to non-obligor subsidiaries | $ | 239,035 | $ | 240,874 | ||||||||||
Long-term debt | 11,407,210 | 9,793,541 | ||||||||||||
Other noncurrent liabilities | 1,193,639 | 1,121,884 | ||||||||||||
Total noncurrent liabilities | $ | 12,839,884 | $ | 11,156,299 |
Combined Parent and Guarantor Subsidiaries Summarized Results of Operations | 39-Week Period Ended Mar. 30, 2024 | |||||||||||||||||||||||||
(In thousands) | ||||||||||||||||||||||||||
Sales | $ | 36,103,081 | ||||||||||||||||||||||||
Gross profit | 6,524,702 | |||||||||||||||||||||||||
Operating income | 1,819,978 | |||||||||||||||||||||||||
Interest expense from non-obligor subsidiaries | 37,270 | |||||||||||||||||||||||||
Net earnings | 1,020,853 |
ISSUER PURCHASES OF EQUITY SECURITIES | |||||||||||||||||||||||
Period |
Total Number of Shares Purchased
(1)
|
Average Price Paid per Share |
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs
(2)
|
Maximum Number of Shares that May Yet Be Purchased Under the Plans or Programs | |||||||||||||||||||
Month #1 | |||||||||||||||||||||||
December 31 - January 27
(3)
|
6,026,110 | $ | — | 6,026,110 | — | ||||||||||||||||||
Month #2 | |||||||||||||||||||||||
January 28 - February 24 | 148 | 80.82 | 148 | — | |||||||||||||||||||
Month #3 | |||||||||||||||||||||||
February 25 - March 30 | 2,554 | 81.14 | 2,554 | — | |||||||||||||||||||
Totals | 6,028,812 | 6,028,812 | — |
(1)
|
The total number of shares purchased includes 0, 148 and 2,554 shares tendered by individuals in connection with stock option exercises in Month #1, Month #2 and Month #3, respectively.
|
||||
(2)
|
See the discussion in Item 2, “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Liquidity and Capital Resources – Equity Transactions” for additional information regarding Sysco’s share repurchase program.
|
||||
(3)
|
In connection with an accelerated share repurchase program (the ASR Program) with a large financial institution, we provided a payment of $500.0 million on January 11, 2024 and received an initial tranche of 6,026,110 shares of the company’s outstanding common stock. Subsequent to March 30, 2024, the ASR Program was settled and resulted in 323,109 incremental shares being delivered to us. This resulted in a total of 6,349,219 shares repurchased under the ASR Program at an average price of $78.75 per share. See Note 10, “Earnings Per Share,” for details of the ASR Program. |
3.1 | — | |||||||
3.2 | — | |||||||
3.3 | — | |||||||
3.4 | — | |||||||
22.1 | — | Subsidiary Guarantors and Issuers of Guaranteed Securities, incorporated by reference to Exhibit 22.1 to the Form 10-K for the year ended July 1, 2023 filed on August 25, 2023 (File No. 1-6544). | ||||||
31.1# | — | |||||||
31.2# | — | |||||||
32.1# | — | |||||||
32.2# | — | |||||||
101.SCH# | — | Inline XBRL Taxonomy Extension Schema Document | ||||||
101.CAL# | — | Inline XBRL Taxonomy Extension Calculation Linkbase Document | ||||||
101.DEF# | — | Inline XBRL Taxonomy Extension Definition Linkbase Document | ||||||
101.LAB# | — | Inline XBRL Taxonomy Extension Labels Linkbase Document | ||||||
101.PRE# | — | Inline XBRL Taxonomy Extension Presentation Linkbase Document | ||||||
104 | — | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |
Sysco Corporation | ||||||||
(Registrant) | ||||||||
Date: April 30, 2024 | By: | /s/ KEVIN P. HOURICAN | ||||||
Kevin P. Hourican | ||||||||
President and Chief Executive Officer | ||||||||
Date: April 30, 2024 | By: | /s/ KENNY K. CHEUNG | ||||||
Kenny K. Cheung | ||||||||
Executive Vice President and | ||||||||
Chief Financial Officer | ||||||||
Date: April 30, 2024 | By: | /s/ JENNIFER L. JOHNSON | ||||||
Jennifer L. Johnson | ||||||||
Senior Vice President and | ||||||||
Chief Accounting Officer |
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
---|
DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
---|---|---|---|
Key Director Qualifications and Board Contributions: • Ms. Talton has extensive experience in executive leadership roles within the information technology system and cybersecurity industries, providing her with a valuable perspective on Sysco’s business technology initiatives and the Board’s approach to privacy and cybersecurity risk oversight. This experience is particularly impactful in Ms. Talton’s role as Chair of Sysco’s Technology Committee. • Ms. Talton has served as an independent director for multiple public companies since 2010, which has provided her with extensive experience in executive compensation, corporate governance, risk management and audit and finance matters. | |||
Key Director Qualifications and Board Contributions: • During his tenure at Natura, a purpose-driven cosmetic group, Mr. Marques established a unique direct to customer, omnichannel experience with a strong digital/e-commerce platform in a relationship selling model. Mr. Marques gained deep expertise in sustainability while at Natura and through his service on the board of the We Mean Business Coalition as well as past roles with the United Nations Global Compact Board and the World Economic Forum. • As Executive Vice President and President for North America at Mondel ē z International, a company that globally markets snacking brands from Kraft, Nabisco, Cadbury, among others, Mr. Marques gained deep, global foodservice experience. • During his more than 25 years at Johnson & Johnson, Mr. Marques gained deep expertise mainly in Consumer Global managing roles, with sales, marketing, and supply chain operations. | |||
• Mr. Glasscock serves as Lead Independent Director to the Board of Directors • Each Board committee has an independent chair | |||
Executive Experience: • Mr. Hourican has served as Sysco’s Chair of the Board and CEO since April 2024, and previously served as President and CEO and a member of Sysco’s Board from February 2020 until April 2024, leading the Company’s large-scale, customer-focused and growth-related transformation, aimed at further improving the way Sysco supports its customers and accelerating profitable sales growth. Since Mr. Hourican joined Sysco, the Company’s focus on elevating customer experience, expanding our specialty distribution reach, and penetrating new international markets has resulted in consistent market share gains and record-breaking financial performance. • Prior to Sysco, he served as Executive Vice President of CVS Health Corporation, a premier health innovation company, and President of CVS Pharmacy, overseeing CVS Health’s $85 billion retail business, including 9,900 retail stores and over 200,000 employees, as well as merchandising, marketing, supply chain, real estate, front store operations, pharmacy growth, pharmacy clinical care and pharmacy operations. • Prior to joining CVS Health, Mr. Hourican held executive leadership roles at Macy’s | |||
Biography: Ms. Johnson has served as Sysco’s Senior Vice President and Chief Accounting Officer since October 2023. Previously, she served as Corporate Vice President and Principal Accounting Officer of FedEx Corporation (“FedEx”) from October 2021 to October 2023, Corporate Vice President and Principal Accounting Officer – Elect from August 2021 to September 2021 and Staff Vice President and Corporate Controller from 2015 to 2021. Ms. Johnson was Vice President – Accounting of FedEx Corporate Services, Inc. from 2013 to 2015. Prior to that, she held various positions in the financial reporting group at FedEx from 2005 through 2013, including Staff Director – Financial Reporting from 2011 through 2013. Ms. Johnson holds bachelor’s and master’s degrees of professional accountancy from Mississippi State University and is a certified public accountant. | |||
Executive Experience: • Ms. Golder served as Senior Vice President and CFO of Cracker Barrel Old Country Store, Inc. (“Cracker Barrel”) from June 2016 to December 2020. • Previously, she served in finance leadership roles at Ruby Tuesday, Inc. (“Ruby Tuesday”), including as Executive Vice President and CFO from June 2014 to April 2016. • Prior to that, Ms. Golder spent 23 years at Darden Restaurants, Inc., where she served in finance positions of increasing responsibility for several Darden brands, including Senior Vice President of Finance for Olive Garden, Smokey Bones, Specialty Restaurant Group and Red Lobster. | |||
Key Director Qualifications and Board Contributions: • During her more than 30-year career at McDonald’s and her time with Ernst & Young, Ms. DeBiase accumulated significant experience in accounting and auditing and corporate finance, culminating in her service as McDonald’s Senior Director of European Finance from 2002 to 2005. • Through her experience at McDonald’s, Ms. DeBiase also developed deep expertise in supply chain and sustainability, pioneering the development of a combined supply chain/sustainability operation, and garnered significant experience with international business through residing in Europe during her service in roles of increasing responsibility from 1996 to 2006, including: Chief European Supply Chain Officer; Senior Director, Europe Finance; Director, Central & Eastern Europe, Finance, Franchising and Human Resources; and Chief Finance Director and Head of IT and Supply Chain (McDonald’s Poland). • Ms. DeBiase gathered significant board room experience, serving for five years as management’s representative for the Sustainability and Corporate Responsibility Committee of the McDonald’s board of directors and regularly attending meetings of the board to present on strategic plans and lead discussions of supply chain, enterprise risk and sustainability matters. | |||
Key Director Qualifications and Board Contributions: • During his close to 40-year career at UPS, Mr. Brutto held several leadership roles with increasing levels of responsibility. Through these roles, he garnered significant experience across strategy development, business operations, marketing and finance that allows him to offer valuable insight to the Board regarding the operation and oversight of a major global company. • Mr. Brutto’s experience at UPS provides him with significant knowledge of supply chain management and associated risk oversight, which brings an invaluable perspective to the Sysco Board as the Company navigates a complex global distribution network. • Through his tenure as a public company director at both Illinois Tool Works and Sysco, Mr. Brutto has gained valuable experience overseeing sustainability and Responsible Growth matters, positioning him well as the Chair of our Sustainability Committee. | |||
Key Director Qualifications and Board Contributions: • During the course of his nearly 30-year career with Caterpillar and his time with PricewaterhouseCoopers LLP, Mr. Halverson developed deep expertise in accounting, financial reporting and corporate finance, which equips him to bring his valuable perspective to the Board, particularly through his role as Audit Committee Chair. • Mr. Halverson’s significant experience in the areas of executive leadership and management, corporate strategy development, mergers and acquisitions, risk management, information technology systems oversight and international business, gained through his senior roles at Caterpillar, allow him to exercise effective oversight of Sysco’s management team’s strategic execution, as well as the Company’s human capital management initiatives. | |||
Key Director Qualifications and Board Contributions: • Throughout her career at both corporations and professional services firms, as well as early- and mid-stage startups, Ms. Paul has developed extensive experience in the areas of executive leadership, finance, human resources, talent management, global operations, marketing, sales and merchandising, strategy development and digital technology and cybersecurity. • Ms. Paul’s leadership of a global technology-driven team and her years of experience advising leading consumer product industry companies on business development, strategic, and marketing initiatives position her to deliver insightful guidance to the Board and management team on Sysco’s strategic growth initiatives. | |||
• Evaluates and approves executive compensation philosophies, policies, plans, and programs, including to ensure that compensation actions link pay and performance, provide a competitive pay opportunity to attract and retain key executive talent, provide accountability for short- and long-term performance, and align the interests of Sysco’s senior officers with the interests of stockholders; • Establishes and approves all compensation, including the corporate goals on which compensation is based, of the CEO and the other senior officers, including the NEO's; • Oversees the process for the evaluation of management, including the CEO; • Reviews and approves any clawback policy allowing the recoupment of compensation paid to colleagues, including the senior officers; • Reviews and approves all employment agreements, separation and severance agreements and other compensatory contracts, arrangements, perquisites and payments with respect to current or former senior officers; • Reviews and determines equity awards for all colleagues that participate in any incentive programs, and oversees management’s exercise of its previously delegated equity grant authority; • Reviews, approves, and recommends the establishment or amendment of any compensation or retirement program (i) in which any senior officer will participate, (ii) that requires stockholder approval, or (iii) that could reasonably be expected to have a material cost impact; • Reviews and discusses with the CEO the Company’s leadership development programs and succession planning for the other senior officers; • Evaluates the independence and any potential conflict of interest raised by the work of a compensation consultant, independent legal counsel or other advisor (whether retained by the CLD Committee or management) prior to selecting or receiving advice, taking into consideration all factors relevant to its independence from management, including any factors required by the NYSE or applicable law; and • Reviews the Company’s human capital policies and strategies. Except for decisions that impact the compensation of Sysco’s CEO, the CLD Committee is generally authorized to delegate any decisions it deems appropriate to a subcommittee. In such a case, the subcommittee must promptly report any action that it takes to the full CLD Committee. In addition, the CLD Committee may delegate to any one or more members of the Board its full equity grant authority (other than for grants made to Sysco’s senior officers). The CLD Committee has delegated such authority to the CEO with respect to certain non- executive employees, subject to specified limitations. For a detailed description of the CLD Committee’s processes and procedures for determining executive compensation, see the “Compensation Discussion and Analysis” section of this Proxy Statement below. The Board has determined that each member of the CLD Committee is independent as defined in the NYSE’s listing standards and the Company’s Corporate Governance Guidelines. COMPENSATION AND LEADERSHIP DEVELOPMENT COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION No member of our CLD Committee is, or has at any time during the past year been, an officer or employee of Sysco or had any relationship requiring disclosure by Sysco under Item 404 of Regulation S-K. During fiscal year 2024, there were no situations where an executive officer of Sysco served on the compensation committee or board of another corporation that had an executive officer serving on Sysco’s Board of Directors or the CLD Committee. |
Name and
Principal Position
|
Fiscal
Year
|
Salary
($)
|
Bonus
($)
|
Stock
Awards
($)
|
Option
Awards
($)
|
Non-Equity
Incentive Plan
Compensation
($)
|
Change in
Pension Value
and Nonqualified
Deferred
Compensation
Earnings
($)
|
All Other
Compensation
($)
|
Total
($)
|
Kevin P. Hourican
Chair of the Board and Chief
Executive Officer
|
2024
|
1,341,760
|
—
|
9,430,664
|
2,399,982
|
2,221,000
|
—
|
204,844
|
15,598,250
|
2023
|
1,296,438
|
—
|
7,775,318
|
3,299,985
|
1,762,976
|
—
|
206,303
|
14,341,020
|
|
2022
|
1,296,438
|
—
|
6,990,845
|
3,146,812
|
2,070,900
|
—
|
151,511
|
13,656,506
|
|
Kenny K. Cheung
Executive Vice President and
Chief Financial Officer
|
2024
|
784,139
|
—
|
2,012,590
|
512,194
|
742,000
|
—
|
254,080
|
4,305,003
|
2023
|
159,288
|
600,000
|
1,686,062
|
745,859
|
144,406
|
—
|
33,760
|
3,369,375
|
|
Greg D. Bertrand
Executive Vice President and
Global Chief Operating Officer
|
2024
|
824,924
|
—
|
2,311,492
|
586,587
|
1,141,000
|
17,650
|
103,082
|
4,984,735
|
2023
|
749,025
|
—
|
1,745,800
|
740,980
|
848,808
|
9,906
|
147,950
|
4,242,469
|
|
2022
|
696,441
|
—
|
3,792,142
|
717,975
|
927,297
|
12,157
|
143,689
|
6,289,701
|
|
Thomas R. Peck, Jr.
Executive Vice President, Chief
Information and Digital Officer
|
2024
|
726,354
|
—
|
2,029,257
|
514,479
|
687,000
|
—
|
55,877
|
4,012,967
|
2023
|
678,480
|
—
|
1,448,101
|
614,607
|
645,847
|
—
|
56,899
|
3,443,934
|
|
2022
|
661,974
|
—
|
1,397,230
|
628,970
|
705,005
|
—
|
86,184
|
3,479,363
|
|
Ronald L. Phillips
Executive Vice President and
Chief Human Resources Officer
|
2024
|
682,363
|
—
|
1,635,867
|
415,180
|
646,000
|
—
|
80,620
|
3,460,030
|
Suppliers
Supplier name | Ticker |
---|---|
Berry Global Group, Inc. | BERY |
Silgan Holdings Inc. | SLGN |
Ball Corporation | BLL |
AptarGroup, Inc. | ATR |
Heartland Express, Inc. | HTLD |
Ingredion Incorporated | INGR |
Bemis Company, Inc. | BMS |
Price
Yield
Owner | Position | Direct Shares | Indirect Shares |
---|---|---|---|
Bertrand Greg D | - | 56,304 | 1,622 |
Bertrand Greg D | - | 50,287 | 1,622 |
McFadden Eve M | - | 48,451 | 0 |
Alt Aaron E | - | 37,166 | 0 |
Peck Thomas R Jr | - | 36,575 | 0 |
Brutto Daniel J | - | 35,449 | 0 |
Peck Thomas R Jr | - | 27,431 | 0 |
Russell Neil | - | 24,082 | 0 |
Russell Neil | - | 24,061 | 0 |
Jasper James Chris | - | 22,531 | 4,188 |
Purefoy Daniel | - | 21,584 | 0 |
Jasper James Chris | - | 18,531 | 4,188 |
Cheung Kenny K | - | 16,295 | 0 |
Talton Sheila | - | 12,738 | 0 |
Johnson Jennifer L | - | 11,996 | 0 |
Gutierrez Victoria L | - | 9,354 | 0 |
Johnson Jennifer L | - | 8,840 | 0 |
Schott Jennifer Kaplan | - | 6,668 | 0 |
Cheung Kenny K | - | 6,564 | 0 |